1	Atherosclerosis	NN	ORGANIZATION	atherosclerosis	_	0	SENT_1	[p1l866t81r1060b103],
2	21	CD	NUMBER	21	number	3	SENT_1	[p1l1069t82r1096b102],
3	1	CD	NUMBER	1	dep	1	SENT_1	[p1l1102t82r1112b102],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l1124t81r1206b108],
5	2010	CD	DATE	2010	dep	3	SENT_1	[p1l1124t81r1206b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1124t81r1206b108],
7	28-29	CD	DATE	28-29	dep	1	SENT_1	[p1l1215t82r1293b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l769t201r906b227],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l920t202r978b227],
3	available	JJ	O	available	amod	2	SENT_2	[p1l990t202r1128b227],
4	at	IN	O	at	_	0	SENT_2	[p1l1140t205r1167b227],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1179t201r1390b227],

1	Atherosclerosis	NN	MISC	atherosclerosis	nn	3	SENT_3	[p1l869t302r1290b349],
2	journal	NN	O	journal	nn	3	SENT_3	[p1l492t424r625b455],
3	homepage	NN	O	homepage	_	0	SENT_3	[p1l648t424r853b455],
4	:	:	O	:	_	0	SENT_3	[p1l648t424r853b455],
5	www.elsevier.com/locate/atherosclerosis	NN	O	www.elsevier.com/locate/atherosclerosis	dep	3	SENT_3	[p1l870t424r1668b449],

1	Letter	NN	O	letter	_	0	SENT_4	[p1l9t590r235b650],
2	to	TO	O	to	_	0	SENT_4	[p1l259t595r332b650],
3	the	DT	O	the	det	4	SENT_4	[p1l359t586r481b650],
4	Editor	NNP	O	Editor	prep_to	1	SENT_4	[p1l509t586r743b650],

1	Genetic	JJ	O	genetic	amod	2	SENT_5	[p1l7t803r261b857],
2	involvement	NN	O	involvement	nsubj	5	SENT_5	[p1l282t803r711b857],
3	in	IN	O	in	_	0	SENT_5	[p1l732t803r798b857],
4	statins	NNS	O	statin	prep_in	2	SENT_5	[p1l819t803r1044b857],
5	induced	VBD	O	induce	_	0	SENT_5	[p1l1067t803r1339b857],
6	myopathy	NN	O	myopathy	dobj	5	SENT_5	[p1l1361t803r1720b871],
7	.	.	O	.	_	0	SENT_5	[p1l1361t803r1720b871],

1	Preliminary	JJ	O	preliminary	amod	2	SENT_6	[p1l1742t803r2149b871],
2	data	NNS	O	datum	_	0	SENT_6	[p1l7t890r154b944],
3	from	IN	O	from	_	0	SENT_6	[p1l174t890r342b944],
4	an	DT	O	a	det	6	SENT_6	[p1l362t905r445b944],
5	observational	JJ	O	observational	amod	6	SENT_6	[p1l465t890r929b944],
6	case	NN	O	case	prep_from	2	SENT_6	[p1l949t890r1382b944],
7	—	CD	NUMBER	—	num	9	SENT_6	[p1l949t890r1382b944],
8	control	NN	O	control	nn	9	SENT_6	[p1l949t890r1382b944],
9	study	NN	O	study	dep	2	SENT_6	[p1l1403t890r1590b958],

1	Dear	NNP	O	Dear	_	0	SENT_7	[p1l6t1068r156b1119],
2	Editor	NNP	O	Editor	dep	1	SENT_7	[p1l172t1065r371b1127],
3	,	,	O	,	_	0	SENT_7	[p1l172t1065r371b1127],

1	Statins	NNS	O	statin	nsubj	4	SENT_8	[p1l110t1243r326b1296],
2	are	VBP	O	be	cop	4	SENT_8	[p1l350t1258r448b1296],
3	relevant	JJ	O	relevant	amod	4	SENT_8	[p1l471t1242r736b1296],
4	drugs	NNS	O	drug	_	0	SENT_8	[p1l757t1242r934b1310],
5	involved	VBN	O	involve	partmod	4	SENT_8	[p1l959t1242r1234b1297],
6	in	IN	O	in	_	0	SENT_8	[p1l1258t1243r1317b1296],
7	the	DT	O	the	det	8	SENT_8	[p1l1339t1242r1440b1296],
8	reduction	NN	O	reduction	prep_in	5	SENT_8	[p1l1464t1242r1774b1296],
9	of	IN	O	of	_	0	SENT_8	[p1l1796t1242r1863b1296],
10	myocardial	JJ	O	myocardial	amod	17	SENT_8	[p1l1879t1258r2145b1310, p1l8t1330r124b1384],
11	infarction	NN	O	infarction	nn	13	SENT_8	[p1l163t1329r490b1392],
12	,	,	O	,	_	0	SENT_8	[p1l163t1329r490b1392],
13	stroke	NN	O	stroke	nn	17	SENT_8	[p1l531t1330r728b1384],
14	and	CC	O	and	_	0	SENT_8	[p1l766t1330r882b1384],
15	cardiovascular	JJ	O	cardiovascular	nn	17	SENT_8	[p1l921t1330r1390b1384],
16	mortality	NN	O	mortality	nn	17	SENT_8	[p1l1427t1330r1728b1397],
17	[	NN	O	[	prep_of	8	SENT_8	[p1l1768t1329r1867b1397],
18	1	CD	NUMBER	1	num	19	SENT_8	[p1l1768t1329r1867b1397],
19	]	NN	O	]	dep	17	SENT_8	[p1l1768t1329r1867b1397],
20	.	.	O	.	_	0	SENT_8	[p1l1768t1329r1867b1397],

1	Related	JJ	O	related	amod	4	SENT_9	[p1l1907t1330r2145b1384],
2	muscular	JJ	O	muscular	amod	4	SENT_9	[p1l9t1417r308b1471],
3	side	NN	O	side	nn	4	SENT_9	[p1l324t1417r449b1471],
4	effects	NNS	O	effect	nsubj	9	SENT_9	[p1l467t1417r674b1471],
5	are	VBP	O	be	cop	9	SENT_9	[p1l692t1433r789b1471],
6	the	DT	O	the	det	9	SENT_9	[p1l806t1417r908b1471],
7	most	RBS	O	most	advmod	8	SENT_9	[p1l926t1425r1085b1471],
8	common	JJ	O	common	amod	9	SENT_9	[p1l1101t1432r1384b1471],
9	cause	NN	O	cause	_	0	SENT_9	[p1l1401t1433r1577b1471],
10	of	IN	O	of	_	0	SENT_9	[p1l1594t1417r1661b1471],
11	withdrawal	NN	O	withdrawal	nn	12	SENT_9	[p1l1668t1417r2041b1471],
12	[	NN	O	[	prep_of	9	SENT_9	[p1l2062t1417r2142b1484],
13	2	CD	NUMBER	2	num	14	SENT_9	[p1l2062t1417r2142b1484],
14	]	NN	O	]	nsubj	19	SENT_9	[p1l2062t1417r2142b1484],
15	and	CC	O	and	_	0	SENT_9	[p1l8t1504r125b1558],
16	statins	NNS	O	statin	nn	17	SENT_9	[p1l145t1505r355b1558],
17	discontinuation	NN	O	discontinuation	nsubj	19	SENT_9	[p1l375t1504r882b1558],
18	could	MD	O	could	aux	19	SENT_9	[p1l900t1504r1074b1558],
19	induce	VB	O	induce	rcmod	9	SENT_9	[p1l1095t1504r1308b1558],
20	increased	VBN	O	increase	amod	22	SENT_9	[p1l1328t1504r1634b1558],
21	vascular	JJ	O	vascular	amod	22	SENT_9	[p1l1652t1504r1920b1558],
22	events	NNS	O	event	nsubj	23	SENT_9	[p1l1937t1512r2145b1558],
23	[	VBP	O	[	ccomp	19	SENT_9	[p1l12t1591r110b1659],
24	2	CD	NUMBER	2	number	25	SENT_9	[p1l12t1591r110b1659],
25	]	CD	NUMBER	]	dobj	23	SENT_9	[p1l12t1591r110b1659],
26	.	.	O	.	_	0	SENT_9	[p1l12t1591r110b1659],

1	The	DT	O	the	det	3	SENT_10	[p1l107t1678r224b1732],
2	female	JJ	O	female	amod	3	SENT_10	[p1l246t1678r460b1732],
3	sex	NN	O	sex	nsubjpass	13	SENT_10	[p1l482t1694r586b1732],
4	and	CC	O	and	_	0	SENT_10	[p1l605t1678r721b1732],
5	association	NN	O	association	nsubjpass	13	SENT_10	[p1l742t1679r1099b1732],
6	with	IN	O	with	_	0	SENT_10	[p1l1118t1678r1265b1732],
7	other	JJ	O	other	amod	8	SENT_10	[p1l1286t1678r1458b1732],
8	drugs	NNS	O	drug	prep_with	3	SENT_10	[p1l1476t1678r1654b1746],
9	are	VBP	O	be	auxpass	13	SENT_10	[p1l1675t1694r1773b1732],
10	well	RB	O	well	advmod	13	SENT_10	[p1l1792t1678r1928b1732],
11	established	JJ	O	established	amod	12	SENT_10	[p1l1949t1678r2145b1732, p1l9t1765r198b1819],
12	conditions	NNS	O	condition	pobj	10	SENT_10	[p1l223t1765r559b1819],
13	associated	VBN	O	associate	_	0	SENT_10	[p1l584t1765r915b1819],
14	with	IN	O	with	_	0	SENT_10	[p1l938t1765r1086b1819],
15	statins	NNS	O	statin	prep_with	13	SENT_10	[p1l1111t1766r1320b1819],
16	side	JJ	O	side	amod	17	SENT_10	[p1l1346t1765r1472b1819],
17	effects	NNS	O	effect	nsubj	18	SENT_10	[p1l1496t1765r1703b1819],
18	[	VBP	O	[	rcmod	15	SENT_10	[p1l1732t1765r1830b1833],
19	2	CD	NUMBER	2	number	20	SENT_10	[p1l1732t1765r1830b1833],
20	]	CD	NUMBER	]	dobj	18	SENT_10	[p1l1732t1765r1830b1833],
21	.	.	O	.	_	0	SENT_10	[p1l1732t1765r1830b1833],

1	However	RB	O	however	advmod	4	SENT_11	[p1l1856t1769r2148b1819],
2	recent	JJ	O	recent	amod	3	SENT_11	[p1l9t1861r211b1907],
3	data	NNS	O	datum	nsubj	4	SENT_11	[p1l252t1853r389b1907],
4	suggest	VBP	O	suggest	_	0	SENT_11	[p1l432t1861r673b1920],
5	a	DT	O	a	det	8	SENT_11	[p1l714t1868r746b1907],
6	speciﬁc	JJ	O	speciﬁc	amod	8	SENT_11	[p1l789t1852r1027b1920],
7	genetic	JJ	O	genetic	amod	8	SENT_11	[p1l1068t1853r1301b1920],
8	inﬂuence	NN	O	inﬂuence	dobj	4	SENT_11	[p1l1343t1852r1638b1907],
9	in	IN	O	in	_	0	SENT_11	[p1l1682t1853r1741b1906],
10	intolerance	NN	O	intolerance	nn	11	SENT_11	[p1l1783t1853r2145b1907],
11	development	NN	O	development	prep_in	8	SENT_11	[p1l8t1940r449b2007],
12	,	,	O	,	_	0	SENT_11	[p1l8t1940r449b2007],
13	at	IN	O	at	advmod	8	SENT_11	[p1l488t1948r548b1994],
14	least	JJS	O	least	pobj	13	SENT_11	[p1l585t1940r734b1994],
15	for	IN	O	for	_	0	SENT_11	[p1l772t1940r861b1994],
16	some	DT	O	some	det	17	SENT_11	[p1l899t1955r1067b1994],
17	statins	NNS	O	statin	prep_for	4	SENT_11	[p1l1107t1941r1333b1994],
18	.	.	O	.	_	0	SENT_11	[p1l1107t1941r1333b1994],

1	Indeed	RB	O	indeed	advmod	23	SENT_12	[p1l1373t1940r1590b1994],
2	a	DT	O	a	det	4	SENT_12	[p1l1629t1956r1662b1994],
3	genome-wide	JJ	O	genome-wide	amod	4	SENT_12	[p1l1699t1940r2145b2007],
4	study	NN	O	study	nsubj	23	SENT_12	[p1l9t2026r186b2094],
5	in	IN	O	in	_	0	SENT_12	[p1l231t2027r289b2080],
6	patients	NNS	O	patient	prep_in	4	SENT_12	[p1l335t2027r593b2094],
7	treated	VBN	O	treat	partmod	6	SENT_12	[p1l639t2026r869b2080],
8	with	IN	O	with	_	0	SENT_12	[p1l913t2026r1061b2080],
9	high	JJ	O	high	amod	11	SENT_12	[p1l1106t2026r1247b2094],
10	dose	NN	O	dose	nn	11	SENT_12	[p1l1292t2026r1437b2080],
11	simvastatin	NN	O	simvastatin	prep_with	7	SENT_12	[p1l1484t2027r1857b2080],
12	(	CD	NUMBER	(	number	13	SENT_12	[p1l1902t2026r2004b2093],
13	80	CD	NUMBER	80	num	15	SENT_12	[p1l1902t2026r2004b2093],
14	mg	NN	O	mg	nn	15	SENT_12	[p1l2021t2026r2145b2094],
15	)	NN	O	)	nsubj	16	SENT_12	[p1l2021t2026r2145b2094],
16	found	VBD	O	find	rcmod	11	SENT_12	[p1l9t2113r193b2167],
17	an	DT	O	a	det	19	SENT_12	[p1l222t2129r297b2167],
18	impressive	JJ	O	impressive	amod	19	SENT_12	[p1l325t2114r674b2181],
19	association	NN	O	association	dobj	16	SENT_12	[p1l702t2114r1059b2167],
20	between	IN	O	between	_	0	SENT_12	[p1l1086t2113r1364b2167],
21	single-nucleotide	JJ	O	single-nucleotide	amod	22	SENT_12	[p1l1392t2113r1951b2181],
22	polymorphisms	NNS	O	polymorphism	prep_between	19	SENT_12	[p1l1980t2113r2145b2181, p1l9t2200r371b2268],
23	(	VBP	O	(	_	0	SENT_12	[p1l401t2200r609b2268],
24	SNPS	NN	O	snp	nn	25	SENT_12	[p1l401t2200r609b2268],
25	)	NN	O	)	nsubj	26	SENT_12	[p1l401t2200r609b2268],
26	located	JJ	O	located	xcomp	23	SENT_12	[p1l639t2200r870b2254],
27	within	IN	O	within	_	0	SENT_12	[p1l898t2200r1110b2254],
28	SLCOIBI	NNP	O	SLCOIBI	nn	29	SENT_12	[p1l1136t2203r1402b2254],
29	gene	NN	O	gene	prep_within	26	SENT_12	[p1l1437t2216r1589b2268],
30	on	IN	O	on	_	0	SENT_12	[p1l1618t2216r1696b2254],
31	chromosome	NN	O	chromosome	prep_on	29	SENT_12	[p1l1726t2200r2145b2254],
32	12	CD	NUMBER	12	num	31	SENT_12	[p1l12t2290r83b2341],
33	and	CC	O	and	_	0	SENT_12	[p1l129t2287r245b2341],
34	established	VBD	O	establish	conj_and	23	SENT_12	[p1l290t2287r653b2341],
35	myopathy	NN	O	myopathy	dobj	34	SENT_12	[p1l698t2287r1025b2355],
36	deﬁned	VBN	O	deﬁned	partmod	35	SENT_12	[p1l1068t2287r1307b2341],
37	as	IN	O	as	_	0	SENT_12	[p1l1352t2303r1414b2341],
38	creatine	NN	O	creatine	nn	39	SENT_12	[p1l1459t2288r1718b2341],
39	kinase	NN	O	kinase	prep_as	36	SENT_12	[p1l1763t2287r1965b2341],
40	(	CD	NUMBER	(	num	42	SENT_12	[p1l2010t2287r2145b2355],
41	CK	NN	O	ck	nn	42	SENT_12	[p1l2010t2287r2145b2355],
42	)	NN	O	)	dep	47	SENT_12	[p1l2010t2287r2145b2355],
43	>	JJR	O	>	dep	42	SENT_12	[p1l10t2377r170b2429],
44	10x	CD	NUMBER	10x	dep	47	SENT_12	[p1l10t2377r170b2429],
45	the	DT	O	the	det	47	SENT_12	[p1l217t2375r319b2429],
46	upper	JJ	O	upper	amod	47	SENT_12	[p1l360t2390r551b2442],
47	limit	NN	O	limit	dep	39	SENT_12	[p1l590t2375r741b2429],
48	of	IN	O	of	_	0	SENT_12	[p1l781t2374r847b2429],
49	normal	JJ	O	normal	amod	65	SENT_12	[p1l881t2375r1110b2429],
50	in	IN	O	in	_	0	SENT_12	[p1l1151t2375r1211b2428],
51	those	DT	O	those	prep_in	49	SENT_12	[p1l1250t2375r1424b2429],
52	with	IN	O	with	_	0	SENT_12	[p1l1463t2375r1611b2429],
53	symptoms	NNS	O	symptom	prep_with	51	SENT_12	[p1l1653t2383r1987b2442],
54	and	CC	O	and	_	0	SENT_12	[p1l2029t2375r2145b2429],
55	>	JJR	O	>	amod	65	SENT_12	[p1l10t2465r129b2516],
56	3	CD	NUMBER	3	dep	57	SENT_12	[p1l10t2465r129b2516],
57	>	JJR	O	>	npadvmod	58	SENT_12	[p1l10t2465r129b2516],
58	<	JJR	O	<	amod	65	SENT_12	[p1l10t2465r129b2516],
59	in	IN	O	in	_	0	SENT_12	[p1l174t2463r233b2515],
60	those	DT	O	those	prep_in	58	SENT_12	[p1l270t2462r443b2516],
61	without	IN	O	without	_	0	SENT_12	[p1l479t2462r737b2516],
62	symptoms	NNS	O	symptom	prep_without	60	SENT_12	[p1l774t2470r1109b2529],
63	[	CD	NUMBER	[	number	64	SENT_12	[p1l1150t2462r1250b2529],
64	3	CD	NUMBER	3	num	62	SENT_12	[p1l1150t2462r1250b2529],
65	]	NN	O	]	prep_of	47	SENT_12	[p1l1150t2462r1250b2529],
66	.	.	O	.	_	0	SENT_12	[p1l1150t2462r1250b2529],

1	Furthermore	RB	O	furthermore	advmod	14	SENT_13	[p1l1289t2462r1713b2524],
2	,	,	O	,	_	0	SENT_13	[p1l1289t2462r1713b2524],
3	the	DT	O	the	det	4	SENT_13	[p1l1751t2462r1852b2516],
4	association	NN	O	association	nsubjpass	14	SENT_13	[p1l1890t2463r2145b2516, p1l8t2550r134b2603],
5	between	IN	O	between	_	0	SENT_13	[p1l167t2549r446b2603],
6	the	DT	O	the	det	10	SENT_13	[p1l479t2549r580b2603],
7	SLCO1B1	NN	O	slco1b1	nn	10	SENT_13	[p1l613t2549r953b2603],
8	*	NN	O	*	nn	10	SENT_13	[p1l613t2549r953b2603],
9	5	CD	NUMBER	5	num	10	SENT_13	[p1l613t2549r953b2603],
10	variant	NN	O	variant	prep_between	4	SENT_13	[p1l986t2550r1215b2603],
11	and	CC	O	and	_	0	SENT_13	[p1l1247t2549r1363b2603],
12	side-effects	NNS	O	side-effect	conj_and	10	SENT_13	[p1l1399t2549r1766b2603],
13	was	VBD	O	be	auxpass	14	SENT_13	[p1l1800t2565r1924b2603],
14	found	VBN	O	find	_	0	SENT_13	[p1l1960t2549r2145b2603],
15	also	RB	O	also	advmod	14	SENT_13	[p1l8t2636r132b2690],
16	in	IN	O	in	_	0	SENT_13	[p1l176t2637r235b2690],
17	patients	NNS	O	patient	prep_in	14	SENT_13	[p1l278t2637r536b2704],
18	treated	VBN	O	treat	partmod	17	SENT_13	[p1l579t2636r808b2690],
19	with	IN	O	with	_	0	SENT_13	[p1l850t2636r998b2690],
20	atorvastatin	NN	O	atorvastatin	prep_with	18	SENT_13	[p1l1041t2637r1428b2690],
21	but	CC	O	but	prep	20	SENT_13	[p1l1469t2636r1577b2690],
22	not	RB	O	not	dep	21	SENT_13	[p1l1618t2644r1737b2699],
23	,	,	O	,	_	0	SENT_13	[p1l1618t2644r1737b2699],
24	apparently	RB	O	apparently	advmod	14	SENT_13	[p1l1781t2636r2145b2704],
25	,	,	O	,	_	0	SENT_13	[p1l1781t2636r2145b2704],
26	with	IN	O	with	_	0	SENT_13	[p1l7t2723r154b2777],
27	pravastatin	NN	O	pravastatin	prep_with	14	SENT_13	[p1l194t2724r556b2791],
28	and	CC	O	and	_	0	SENT_13	[p1l594t2723r710b2777],
29	categorized	VBN	O	categorize	conj_and	14	SENT_13	[p1l750t2723r1121b2791],
30	as	IN	O	as	_	0	SENT_13	[p1l1161t2739r1222b2777],
31	carriers	NNS	O	carrier	prep_as	29	SENT_13	[p1l1263t2724r1503b2777],
32	of	IN	O	of	_	0	SENT_13	[p1l1544t2723r1610b2777],
33	mild-myopathy	JJ	O	mild-myopathy	prep_of	31	SENT_13	[p1l1642t2723r2147b2791],
34	deﬁned	VBN	O	deﬁned	partmod	33	SENT_13	[p1l8t2810r248b2865],
35	as	IN	O	as	_	0	SENT_13	[p1l280t2826r342b2865],
36	myalgia/muscle	JJ	O	myalgia/muscle	amod	37	SENT_13	[p1l375t2810r883b2878],
37	cramps	NNS	O	cramp	npadvmod	45	SENT_13	[p1l915t2826r1148b2878],
38	irrespective	RB	O	irrespective	advmod	37	SENT_13	[p1l1181t2811r1558b2878],
39	of	IN	O	of	_	0	SENT_13	[p1l1591t2810r1657b2865],
40	CK	NN	O	ck	nn	41	SENT_13	[p1l1681t2813r1766b2865],
41	values	NNS	O	value	prep_of	38	SENT_13	[p1l1794t2811r1997b2865],
42	and	CC	O	and	_	0	SENT_13	[p1l2029t2811r2145b2865],
43	CK	NN	O	ck	nn	44	SENT_13	[p1l9t2900r94b2952],
44	elevations	NNS	O	elevation	conj_and	41	SENT_13	[p1l140t2898r466b2952],
45	>	JJR	O	>	prep_as	34	SENT_13	[p1l517t2900r636b2952],
46	3x	IN	O	3x	_	0	SENT_13	[p1l517t2900r636b2952],
47	the	DT	O	the	det	49	SENT_13	[p1l690t2898r792b2952],
48	upper	JJ	O	upper	amod	49	SENT_13	[p1l841t2913r1031b2965],
49	limit	NN	O	limit	prep_3x	34	SENT_13	[p1l1077t2898r1228b2952],
50	of	IN	O	of	_	0	SENT_13	[p1l1275t2897r1342b2952],
51	normal	JJ	O	normal	amod	57	SENT_13	[p1l1382t2898r1611b2952],
52	irrespective	JJ	O	irrespective	_	0	SENT_13	[p1l1660t2898r2039b2965],
53	of	IN	O	of	_	0	SENT_13	[p1l2087t2897r2153b2952],
54	symptoms	NNS	O	symptom	prep_irrespective_of	57	SENT_13	[p1l9t2993r343b3052],
55	[	CD	NUMBER	[	number	56	SENT_13	[p1l395t2985r494b3052],
56	4	CD	NUMBER	4	dep	54	SENT_13	[p1l395t2985r494b3052],
57	]	NN	O	]	prep_of	49	SENT_13	[p1l395t2985r494b3052],
58	.	.	O	.	_	0	SENT_13	[p1l395t2985r494b3052],

1	However	RB	O	however	advmod	5	SENT_14	[p1l543t2988r835b3039],
2	another	DT	O	another	det	4	SENT_14	[p1l880t2985r1132b3039],
3	relevant	JJ	O	relevant	amod	4	SENT_14	[p1l1177t2985r1442b3039],
4	issue	NN	O	issue	nsubj	5	SENT_14	[p1l1488t2986r1646b3039],
5	is	VBZ	O	be	_	0	SENT_14	[p1l1694t2986r1740b3039],
6	that	IN	O	that	complm	36	SENT_14	[p1l1788t2985r1931b3047],
7	,	,	O	,	_	0	SENT_14	[p1l1788t2985r1931b3047],
8	apart	RB	O	apart	_	0	SENT_14	[p1l1980t2993r2147b3052],
9	from	IN	O	from	_	0	SENT_14	[p1l9t3071r162b3125],
10	genetic	JJ	O	genetic	amod	11	SENT_14	[p1l189t3072r422b3139],
11	inﬂuence	NN	O	inﬂuence	prep_apart_from	36	SENT_14	[p1l451t3071r746b3125],
12	in	IN	O	in	_	0	SENT_14	[p1l776t3072r835b3125],
13	liver	NN	O	liver	nn	14	SENT_14	[p1l864t3071r1008b3125],
14	transporters	NNS	O	transporter	prep_in	11	SENT_14	[p1l1034t3079r1430b3139],
15	inﬂuencing	VBG	O	inﬂuencing	partmod	14	SENT_14	[p1l1460t3071r1822b3139],
16	drug	NN	O	drug	nn	17	SENT_14	[p1l1849t3071r1998b3139],
17	levels	NNS	O	level	nsubj	19	SENT_14	[p1l2025t3071r2145b3125, p1l8t3158r92b3212],
18	such	PDT	O	such	predet	19	SENT_14	[p1l144t3158r289b3212],
19	the	DT	O	the	xcomp	15	SENT_14	[p1l339t3158r440b3212],
20	above	JJ	O	above	advmod	15	SENT_14	[p1l491t3158r694b3221],
21	,	,	O	,	_	0	SENT_14	[p1l491t3158r694b3221],
22	the	DT	O	the	det	23	SENT_14	[p1l745t3158r846b3212],
23	complexity	NN	O	complexity	nsubjpass	36	SENT_14	[p1l897t3158r1259b3226],
24	of	IN	O	of	_	0	SENT_14	[p1l1308t3158r1374b3212],
25	mechanisms	NNS	O	mechanism	prep_of	23	SENT_14	[p1l1417t3158r1818b3212],
26	involved	VBN	O	involve	partmod	25	SENT_14	[p1l1870t3158r2145b3212],
27	in	IN	O	in	_	0	SENT_14	[p1l9t3246r68b3299],
28	the	DT	O	the	det	31	SENT_14	[p1l108t3245r210b3299],
29	muscular	JJ	O	muscular	amod	31	SENT_14	[p1l253t3245r552b3299],
30	side	NN	O	side	nn	31	SENT_14	[p1l592t3245r717b3299],
31	effects	NNS	O	effect	prep_in	26	SENT_14	[p1l760t3245r967b3299],
32	of	IN	O	of	_	0	SENT_14	[p1l1009t3245r1076b3299],
33	statins	NNS	O	statin	prep_of	31	SENT_14	[p1l1111t3246r1320b3299],
34	has	VBZ	O	have	aux	36	SENT_14	[p1l1363t3245r1468b3299],
35	been	VBN	O	be	auxpass	36	SENT_14	[p1l1510t3245r1664b3299],
36	addressed	VBN	O	address	ccomp	5	SENT_14	[p1l1705t3245r2029b3299],
37	by	IN	O	by	_	0	SENT_14	[p1l2070t3245r2147b3313],
38	the	DT	O	the	det	39	SENT_14	[p1l8t3333r109b3387],
39	evidence	NN	O	evidence	agent	36	SENT_14	[p1l152t3333r436b3387],
40	of	IN	O	of	_	0	SENT_14	[p1l479t3332r545b3387],
41	other	JJ	O	other	amod	43	SENT_14	[p1l580t3333r752b3387],
42	inﬂuencing	NN	O	inﬂuencing	nn	43	SENT_14	[p1l793t3332r1155b3400],
43	pathways	NNS	O	pathway	prep_of	39	SENT_14	[p1l1196t3333r1522b3400],
44	.	.	O	.	_	0	SENT_14	[p1l1196t3333r1522b3400],

1	Among	IN	O	among	_	0	SENT_15	[p1l1562t3335r1794b3400],
2	them	PRP	O	they	prep_among	23	SENT_15	[p1l1835t3333r2002b3387],
3	the	DT	O	the	det	4	SENT_15	[p1l2044t3333r2145b3387],
4	variant	NN	O	variant	nsubjpass	23	SENT_15	[p1l6t3421r235b3474],
5	within	IN	O	within	_	0	SENT_15	[p1l269t3420r481b3474],
6	the	DT	O	the	det	8	SENT_15	[p1l518t3420r619b3474],
7	COQ2	NN	O	coq2	nn	8	SENT_15	[p1l657t3423r828b3484],
8	gene	NN	O	gene	dep	9	SENT_15	[p1l863t3436r1015b3487],
9	involved	VBN	O	involve	amod	20	SENT_15	[p1l1052t3420r1328b3474],
10	in	IN	O	in	_	0	SENT_15	[p1l1366t3421r1425b3473],
11	coenzyme	NN	O	coenzyme	nn	14	SENT_15	[p1l1461t3435r1786b3487],
12	Q10	NN	O	q10	nn	14	SENT_15	[p1l1824t3423r1930b3486],
13	mildasymptomatic	JJ	O	mildasymptomatic	amod	14	SENT_15	[p1l1972t3420r2145b3474, p1l8t3508r468b3574],
14	deﬁciency	NN	O	deﬁciency	prep_in	9	SENT_15	[p1l505t3507r832b3574],
15	and	CC	O	and	_	0	SENT_15	[p1l867t3507r983b3561],
16	skeletal	JJ	O	skeletal	amod	19	SENT_15	[p1l1021t3507r1265b3561],
17	muscle	NN	O	muscle	nn	19	SENT_15	[p1l1303t3507r1529b3561],
18	drug	NN	O	drug	nn	19	SENT_15	[p1l1566t3507r1714b3574],
19	transporters	NNS	O	transporter	prep_in	9	SENT_15	[p1l1749t3515r2145b3574],
20	expression	NN	O	expression	prep_within	4	SENT_15	[p1l8t3594r356b3661],
21	has	VBZ	O	have	aux	23	SENT_15	[p1l382t3593r486b3647],
22	been	VBN	O	be	auxpass	23	SENT_15	[p1l513t3593r666b3647],
23	associated	VBN	O	associate	_	0	SENT_15	[p1l692t3593r1023b3647],
24	with	IN	O	with	_	0	SENT_15	[p1l1048t3593r1197b3647],
25	statins	NNS	O	statin	prep_with	23	SENT_15	[p1l1223t3594r1432b3647],
26	muscular	JJ	O	muscular	amod	27	SENT_15	[p1l1460t3593r1759b3647],
27	intolerance	NN	O	intolerance	dep	25	SENT_15	[p1l1783t3593r2145b3647],
28	[	CD	NUMBER	[	number	29	SENT_15	[p1l12t3680r168b3748],
29	5,6	CD	NUMBER	5,6	num	30	SENT_15	[p1l12t3680r168b3748],
30	]	NN	O	]	dep	27	SENT_15	[p1l12t3680r168b3748],
31	.	.	O	.	_	0	SENT_15	[p1l12t3680r168b3748],

1	In	IN	O	in	_	0	SENT_16	[p2l110t20r170b70],
2	June	NNP	DATE	June	prep_in	5	SENT_16	[p2l204t20r351b84],
3	2009	CD	DATE	2009	num	2	SENT_16	[p2l394t19r552b70],
4	we	PRP	O	we	nsubj	5	SENT_16	[p2l593t32r688b70],
5	started	VBD	O	start	_	0	SENT_16	[p2l731t16r954b70],
6	an	DT	O	a	det	10	SENT_16	[p2l997t32r1072b70],
7	actually	RB	O	actually	advmod	10	SENT_16	[p2l1114t16r1367b84],
8	ongoing	JJ	O	ongoing	amod	10	SENT_16	[p2l1408t17r1668b84],
9	observational	JJ	O	observational	amod	10	SENT_16	[p2l1709t16r2145b70],
10	study	NN	O	study	dobj	5	SENT_16	[p2l9t104r186b171],
11	in	IN	O	in	_	0	SENT_16	[p2l239t104r298b157],
12	patients	NNS	O	patient	prep_in	5	SENT_16	[p2l351t104r609b171],
13	referring	VBG	O	refer	partmod	12	SENT_16	[p2l664t103r947b171],
14	to	TO	O	to	_	0	SENT_16	[p2l999t112r1061b158],
15	our	PRP$	O	we	poss	16	SENT_16	[p2l1115t119r1223b158],
16	Centre	NNP	O	Centre	prep_to	13	SENT_16	[p2l1275t106r1484b158],
17	in	IN	O	in	_	0	SENT_16	[p2l1539t104r1598b157],
18	Siena	NNP	LOCATION	Siena	prep_in	16	SENT_16	[p2l1652t104r1822b158],
19	(	CD	NUMBER	(	num	18	SENT_16	[p2l1875t104r2148b171],
20	directly	RB	O	directly	advmod	16	SENT_16	[p2l1875t104r2148b171],
21	and/or	JJ	O	and/or	amod	23	SENT_16	[p2l8t191r221b258],
22	counselling	NN	O	counselling	nn	23	SENT_16	[p2l247t191r640b258],
23	)	NN	O	)	dep	16	SENT_16	[p2l247t191r640b258],
24	treated	VBN	O	treat	partmod	23	SENT_16	[p2l668t191r897b245],
25	with	IN	O	with	_	0	SENT_16	[p2l924t191r1072b245],
26	statins	NNS	O	statin	prep_with	24	SENT_16	[p2l1101t192r1310b245],
27	for	IN	O	for	_	0	SENT_16	[p2l1340t191r1430b245],
28	dyslipidaemia	NN	O	dyslipidaemia	nn	29	SENT_16	[p2l1455t191r1908b258],
29	and/or	NN	O	and/or	prep_for	26	SENT_16	[p2l1935t191r2148b258],
30	atherothrombotic	JJ	O	atherothrombotic	amod	32	SENT_16	[p2l8t277r582b331],
31	risk	NN	O	risk	nn	32	SENT_16	[p2l597t277r715b331],
32	(	NN	O	(	tmod	24	SENT_16	[p2l729t277r901b344],
33	both	CC	O	both	dep	32	SENT_16	[p2l729t277r901b344],
34	primary	JJ	O	primary	conj_or	32	SENT_16	[p2l917t278r1175b345],
35	or	CC	O	or	_	0	SENT_16	[p2l1190t293r1256b331],
36	secondary	JJ	O	secondary	amod	38	SENT_16	[p2l1271t277r1598b345],
37	prevention	NN	O	prevention	nn	38	SENT_16	[p2l1613t277r1991b345],
38	)	NN	O	)	conj_or	32	SENT_16	[p2l1613t277r1991b345],
39	who	WP	O	who	nsubj	40	SENT_16	[p2l2006t277r2145b331],
40	experienced	VBD	O	experience	rcmod	38	SENT_16	[p2l8t364r402b432],
41	intolerance	NN	O	intolerance	nsubj	42	SENT_16	[p2l425t364r787b418],
42	due	JJ	O	due	xcomp	40	SENT_16	[p2l811t364r927b418],
43	to	TO	O	to	_	0	SENT_16	[p2l949t372r1011b418],
44	any	DT	O	any	det	45	SENT_16	[p2l1034t380r1149b432],
45	cause	NN	O	cause	prep_to	42	SENT_16	[p2l1170t380r1362b427],
46	,	,	O	,	_	0	SENT_16	[p2l1170t380r1362b427],
47	in	IN	O	in	mark	50	SENT_16	[p2l1386t365r1445b418],
48	order	NN	O	order	dep	50	SENT_16	[p2l1468t364r1642b418],
49	to	TO	O	to	aux	50	SENT_16	[p2l1662t372r1724b418],
50	explore	VB	O	explore	purpcl	40	SENT_16	[p2l1747t364r1988b432],
51	speciﬁc	NN	O	speciﬁc	nn	52	SENT_16	[p2l2012t380r2145b432, p2l8t451r137b505],
52	associations	NNS	O	association	dobj	50	SENT_16	[p2l166t452r554b505],
53	with	IN	O	with	_	0	SENT_16	[p2l583t451r731b505],
54	genetic	JJ	O	genetic	amod	55	SENT_16	[p2l760t452r993b519],
55	and/or	NN	O	and/or	prep_with	50	SENT_16	[p2l1023t451r1235b519],
56	environmental	JJ	O	environmental	amod	57	SENT_16	[p2l1263t451r1738b505],
57	factors	NNS	O	factor	dep	32	SENT_16	[p2l1769t451r2000b506],
58	.	.	O	.	_	0	SENT_16	[p2l1769t451r2000b506],

1	The	DT	O	the	det	2	SENT_17	[p2l2028t451r2145b505],
2	study	NN	O	study	nsubj	7	SENT_17	[p2l9t538r186b606],
3	was	VBD	O	be	cop	7	SENT_17	[p2l205t554r329b592],
4	a	DT	O	a	det	7	SENT_17	[p2l352t554r384b592],
5	case	NN	O	case	nn	7	SENT_17	[p2l405t538r813b592],
6	—	CD	NUMBER	—	num	7	SENT_17	[p2l405t538r813b592],
7	control	NN	O	control	_	0	SENT_17	[p2l405t538r813b592],
8	in	IN	O	in	_	0	SENT_17	[p2l836t539r894b592],
9	which	WDT	O	which	rel	11	SENT_17	[p2l914t538r1113b592],
10	we	PRP	O	we	nsubj	11	SENT_17	[p2l1132t554r1226b592],
11	recruited	VBD	O	recruit	rcmod	7	SENT_17	[p2l1249t538r1541b592],
12	subjects	NNS	O	subject	dobj	11	SENT_17	[p2l1564t538r1822b606],
13	with	IN	O	with	_	0	SENT_17	[p2l1844t538r1992b592],
14	previous	JJ	O	previous	amod	17	SENT_17	[p2l2014t554r2145b606, p2l6t626r176b680],
15	documented	VBN	O	document	amod	17	SENT_17	[p2l205t626r608b680],
16	real	JJ	O	real	amod	17	SENT_17	[p2l637t626r755b680],
17	intolerance	NN	O	intolerance	conj_or	17	SENT_17	[p2l784t626r1146b680],
18	to	TO	O	to	_	0	SENT_17	[p2l1174t634r1236b680],
19	statins	NNS	O	statin	prep_to	17	SENT_17	[p2l1265t626r1491b688],
20	,	,	O	,	_	0	SENT_17	[p2l1265t626r1491b688],
21	mainly	RB	O	mainly	advmod	23	SENT_17	[p2l1520t626r1742b693],
22	undesirable	JJ	O	undesirable	amod	23	SENT_17	[p2l1769t626r2145b680],
23	CK	NN	O	ck	conj_and	19	SENT_17	[p2l9t716r94b767],
24	and	CC	O	and	_	0	SENT_17	[p2l111t713r252b780],
25	/	:	O	/	punct	27	SENT_17	[p2l111t713r252b780],
26	or	CC	O	or	dep	27	SENT_17	[p2l258t729r324b767],
27	liver	NN	O	liver	dep	19	SENT_17	[p2l342t713r485b767],
28	enzymes	NNS	O	enzyme	conj_and	19	SENT_17	[p2l503t728r801b780],
29	,	,	O	,	_	0	SENT_17	[p2l503t728r801b780],
30	or	CC	O	or	_	0	SENT_17	[p2l822t729r888b767],
31	with	IN	O	with	_	0	SENT_17	[p2l904t713r1052b767],
32	new-onset	NN	O	new-onset	nn	33	SENT_17	[p2l1072t721r1415b767],
33	symptoms	NNS	O	symptom	prep_with	17	SENT_17	[p2l1434t721r1769b780],
34	and/or	JJ	O	and/or	amod	36	SENT_17	[p2l1789t713r2002b780],
35	biochemical	JJ	O	biochemical	amod	36	SENT_17	[p2l2019t713r2145b767, p2l8t799r294b853],
36	alterations	NNS	O	alteration	tmod	33	SENT_17	[p2l322t799r681b862],
37	,	,	O	,	_	0	SENT_17	[p2l322t799r681b862],
38	as	IN	O	as	mark	40	SENT_17	[p2l709t815r771b853],
39	previously	RB	DATE	previously	advmod	40	SENT_17	[p2l800t799r1138b867],
40	stated	VBN	O	state	dep	36	SENT_17	[p2l1164t799r1357b853],
41	[	NN	O	[	nn	43	SENT_17	[p2l1388t799r1487b867],
42	4	CD	NUMBER	4	num	43	SENT_17	[p2l1388t799r1487b867],
43	]	NN	O	]	dobj	40	SENT_17	[p2l1388t799r1487b867],
44	.	.	O	.	_	0	SENT_17	[p2l1388t799r1487b867],

1	The	DT	O	the	det	2	SENT_18	[p2l1512t799r1629b853],
2	study	NN	O	study	nsubjpass	5	SENT_18	[p2l1657t799r1834b867],
3	has	VBZ	O	have	aux	5	SENT_18	[p2l1860t799r1964b853],
4	been	VBN	O	be	auxpass	5	SENT_18	[p2l1992t799r2146b853],
5	performed	VBN	O	perform	_	0	SENT_18	[p2l9t886r348b954],
6	in	IN	O	in	_	0	SENT_18	[p2l365t887r424b940],
7	previously	RB	DATE	previously	advmod	8	SENT_18	[p2l439t886r777b954],
8	diagnosed	VBN	O	diagnose	dep	11	SENT_18	[p2l791t886r1117b954],
9	and	CC	O	and	_	0	SENT_18	[p2l1133t886r1249b940],
10	new-onset	JJ	O	new-onset	conj_and	8	SENT_18	[p2l1266t894r1609b940],
11	subjects	NNS	O	subject	prep_in	5	SENT_18	[p2l1624t886r1882b954],
12	in	IN	O	in	mark	15	SENT_18	[p2l1899t887r1958b940],
13	order	NN	O	order	dep	15	SENT_18	[p2l1974t886r2148b940],
14	to	TO	O	to	aux	15	SENT_18	[p2l8t981r69b1027],
15	reach	VB	O	reach	purpcl	5	SENT_18	[p2l99t973r273b1027],
16	an	DT	O	a	det	18	SENT_18	[p2l300t989r375b1027],
17	adequate	JJ	O	adequate	amod	18	SENT_18	[p2l403t973r697b1041],
18	cohort	NN	O	cohort	dobj	15	SENT_18	[p2l726t973r934b1027],
19	according	VBG	O	accord	_	0	SENT_18	[p2l961t973r1274b1041],
20	to	TO	O	to	prepc_according_to	15	SENT_18	[p2l1301t981r1362b1027],
21	a	DT	O	a	det	22	SENT_18	[p2l1391t989r1423b1027],
22	calculation	NN	O	calculation	pobj	15	SENT_18	[p2l1451t973r1802b1027],
23	of	IN	O	of	_	0	SENT_18	[p2l1830t973r1896b1027],
24	sample	NN	O	sample	nn	25	SENT_18	[p2l1918t973r2145b1041],
25	size	NN	O	size	prep_of	22	SENT_18	[p2l9t1061r128b1114],
26	using	VBG	O	use	dep	15	SENT_18	[p2l162t1061r335b1128],
27	minor	JJ	O	minor	amod	29	SENT_18	[p2l368t1061r563b1114],
28	allele	NN	O	allele	nn	29	SENT_18	[p2l595t1060r763b1114],
29	frequency	NN	O	frequency	nsubj	30	SENT_18	[p2l799t1060r1121b1128],
30	>	JJR	O	>	xcomp	26	SENT_18	[p2l1154t1063r1341b1123],
31	0.05	CD	NUMBER	0.05	advmod	26	SENT_18	[p2l1154t1063r1341b1123],
32	,	,	O	,	_	0	SENT_18	[p2l1154t1063r1341b1123],
33	risk	NN	O	risk	dep	26	SENT_18	[p2l1376t1061r1493b1114],
34	>	JJR	O	>	amod	35	SENT_18	[p2l1527t1063r1656b1115],
35	l.	NN	O	l.	tmod	33	SENT_18	[p2l1527t1063r1656b1115],
36	2	CD	NUMBER	2	dep	35	SENT_18	[p2l1527t1063r1656b1115],
37	at	IN	O	at	_	0	SENT_18	[p2l1691t1068r1751b1114],
38	a	DT	O	a	det	39	SENT_18	[p2l1783t1076r1816b1114],
39	power	NN	O	power	prep_at	33	SENT_18	[p2l1849t1076r2055b1128],
40	of	IN	O	of	_	0	SENT_18	[p2l2087t1060r2153b1114],
41	90	CD	PERCENT	90	num	42	SENT_18	[p2l8t1150r130b1202],
42	%	NN	PERCENT	%	prep_of	39	SENT_18	[p2l8t1150r130b1202],
43	(	CD	NUMBER	(	num	44	SENT_18	[p2l157t1148r541b1215],
44	association	NN	O	association	advmod	39	SENT_18	[p2l157t1148r541b1215],
45	at	IN	O	at	_	0	SENT_18	[p2l569t1156r628b1202],
46	p	NN	O	p	npadvmod	47	SENT_18	[p2l650t1160r738b1215],
47	<	JJR	O	<	prep_at	44	SENT_18	[p2l650t1160r738b1215],
48	0.001	CD	NUMBER	0.001	num	49	SENT_18	[p2l756t1148r956b1215],
49	)	NN	O	)	dep	39	SENT_18	[p2l756t1148r956b1215],
50	matched	VBN	O	match	partmod	49	SENT_18	[p2l986t1148r1263b1202],
51	for	IN	O	for	_	0	SENT_18	[p2l1293t1147r1382b1202],
52	associated	JJ	O	associated	amod	53	SENT_18	[p2l1409t1148r1740b1202],
53	genetic	JJ	O	genetic	prep_for	50	SENT_18	[p2l1768t1148r2001b1215],
54	and	CC	O	and	_	0	SENT_18	[p2l2029t1148r2145b1202],
55	environmental	JJ	O	environmental	amod	56	SENT_18	[p2l8t1236r483b1290],
56	factors	NNS	O	factor	prep_for	50	SENT_18	[p2l507t1236r738b1290],
57	.	.	O	.	_	0	SENT_18	[p2l507t1236r738b1290],

1	Each	DT	O	each	nsubj	3	SENT_19	[p2l110t1322r259b1376],
2	subject	JJ	O	subject	advmod	3	SENT_19	[p2l297t1322r526b1390],
3	gave	VBD	O	give	_	0	SENT_19	[p2l562t1338r708b1390],
4	written	VBN	O	write	amod	6	SENT_19	[p2l745t1323r986b1376],
5	informed	VBN	O	inform	amod	6	SENT_19	[p2l1024t1322r1319b1376],
6	consent	NN	O	consent	dobj	3	SENT_19	[p2l1358t1330r1609b1376],
7	to	TO	O	to	aux	8	SENT_19	[p2l1645t1330r1706b1376],
8	perform	VB	O	perform	xcomp	3	SENT_19	[p2l1745t1322r2006b1390],
9	the	DT	O	the	det	11	SENT_19	[p2l2044t1322r2145b1376],
10	genetic	JJ	O	genetic	amod	11	SENT_19	[p2l7t1410r241b1477],
11	evaluation	NN	O	evaluation	dobj	8	SENT_19	[p2l272t1409r610b1463],
12	exclusively	RB	O	exclusively	prep	8	SENT_19	[p2l642t1409r1000b1477],
13	for	IN	O	for	dep	18	SENT_19	[p2l1031t1409r1120b1463],
14	this	DT	O	this	det	16	SENT_19	[p2l1149t1409r1266b1463],
15	study	NN	O	study	nn	16	SENT_19	[p2l1300t1409r1477b1477],
16	purpose	NN	O	purpose	pobj	13	SENT_19	[p2l1508t1425r1766b1477],
17	when	WRB	O	when	dep	16	SENT_19	[p2l1797t1409r1978b1463],
18	sug0021-9150	NN	O	sug0021-9150	dep	12	SENT_19	[p2l2010t1425r2145b1477, p2l8t1630r337b1685],
19	/	:	O	/	punct	18	SENT_19	[p2l2010t1425r2145b1477, p2l8t1630r337b1685],
20	$	$	MONEY	$	dep	3	SENT_19	[p2l2010t1425r2145b1477, p2l8t1630r337b1685],

1	—	NN	O	—	nsubj	2	SENT_20	[p2l356t1656r383b1661],
2	see	VB	O	see	_	0	SENT_20	[p2l403t1643r483b1674],
3	front	JJ	O	front	amod	4	SENT_20	[p2l501t1631r628b1674],
4	matter	NN	O	matter	dobj	2	SENT_20	[p2l645t1637r819b1674],
5	©	CD	NUMBER	©	num	9	SENT_20	[p2l835t1634r876b1674],
6	2010	CD	DATE	2010	num	9	SENT_20	[p2l894t1633r1020b1674],
7	Elsevier	NNP	ORGANIZATION	Elsevier	nn	9	SENT_20	[p2l1039t1631r1241b1674],
8	Ireland	NNP	ORGANIZATION	Ireland	nn	9	SENT_20	[p2l1257t1631r1437b1674],
9	Ltd.	NNP	ORGANIZATION	Ltd.	dep	4	SENT_20	[p2l1456t1631r1546b1675],
10	.	.	O	.	_	0	SENT_20	[p2l1456t1631r1546b1675],

1	All	DT	O	all	det	2	SENT_21	[p2l1563t1631r1632b1674],
2	rights	NNS	O	rights	nsubj	3	SENT_21	[p2l1651t1631r1797b1685],
3	reserved	VBN	O	reserve	_	0	SENT_21	[p2l1816t1631r2049b1675],
4	.	.	O	.	_	0	SENT_21	[p2l1816t1631r2049b1675],

1	doi	FW	O	doi	_	0	SENT_22	[p2l8t1702r1090b1756],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_22	[p2l8t1702r1090b1756],
3	/	:	O	/	punct	5	SENT_22	[p2l8t1702r1090b1756],
4	j.	NN	O	j.	nn	5	SENT_22	[p2l8t1702r1090b1756],
5	atherosclerosis	NN	O	atherosclerosis	dep	2	SENT_22	[p2l8t1702r1090b1756],
6	.2010.02.026	CD	NUMBER	.2010.02.026	dep	2	SENT_22	[p2l8t1702r1090b1756],

1	gested	VBN	O	gest	_	0	SENT_23	[p2l11t1909r219b1977],
2	at	IN	O	at	_	0	SENT_23	[p2l260t1917r319b1963],
3	regular	JJ	O	regular	amod	4	SENT_23	[p2l359t1909r589b1977],
4	follow-up	NN	O	follow-up	prep_at	1	SENT_23	[p2l628t1909r957b1977],
5	,	,	O	,	_	0	SENT_23	[p2l628t1909r957b1977],
6	also	RB	O	also	advmod	4	SENT_23	[p2l998t1909r1122b1963],
7	patients	NNS	O	patient	dep	4	SENT_23	[p2l1164t1910r1421b1977],
8	with	IN	O	with	_	0	SENT_23	[p2l1461t1909r1609b1963],
9	previous	JJ	O	previous	amod	11	SENT_23	[p2l1649t1910r1924b1977],
10	statin	NN	O	statin	nn	11	SENT_23	[p2l1967t1910r2146b1963],
11	withdrawal	NN	O	withdrawal	prep_with	1	SENT_23	[p2l10t1996r383b2050],
12	referring	VBG	O	refer	partmod	11	SENT_23	[p2l440t1996r722b2064],
13	to	TO	O	to	_	0	SENT_23	[p2l777t2004r838b2050],
14	the	DT	O	the	det	15	SENT_23	[p2l894t1996r996b2050],
15	Centre	NNP	O	Centre	prep_to	12	SENT_23	[p2l1053t1999r1262b2050],
16	for	IN	O	for	_	0	SENT_23	[p2l1319t1996r1408b2050],
17	alternative	JJ	O	alternative	amod	18	SENT_23	[p2l1462t1996r1808b2050],
18	management	NN	O	management	prep_for	15	SENT_23	[p2l1866t2012r2145b2064, p2l13t2076r194b2123],
19	.	.	O	.	_	0	SENT_23	[p2l1866t2012r2145b2064, p2l13t2076r194b2123],

1	The	DT	O	the	det	4	SENT_24	[p2l111t2155r227b2209],
2	ongoing	JJ	O	ongoing	amod	4	SENT_24	[p2l258t2156r517b2223],
3	genetic	JJ	O	genetic	amod	4	SENT_24	[p2l543t2156r777b2223],
4	study	NN	O	study	nsubj	5	SENT_24	[p2l806t2155r983b2223],
5	consists	VBZ	O	consist	_	0	SENT_24	[p2l1011t2156r1263b2209],
6	of	IN	O	of	_	0	SENT_24	[p2l1293t2155r1360b2209],
7	polymerase	NN	O	polymerase	nn	13	SENT_24	[p2l1382t2155r1754b2223],
8	chain	NN	O	chain	nn	13	SENT_24	[p2l1784t2155r1956b2209],
9	reaction	NN	O	reaction	nn	13	SENT_24	[p2l1986t2171r2145b2209, p2l12t2243r138b2297],
10	(	CD	NUMBER	(	num	13	SENT_24	[p2l166t2243r338b2310],
11	PCR	NN	O	pcr	nn	13	SENT_24	[p2l166t2243r338b2310],
12	)	NN	O	)	nn	13	SENT_24	[p2l166t2243r338b2310],
13	evaluation	NN	O	evaluation	prep_of	5	SENT_24	[p2l367t2243r705b2297],
14	of	IN	O	of	_	0	SENT_24	[p2l733t2242r799b2297],
15	previously	RB	DATE	previously	amod	37	SENT_24	[p2l820t2243r1158b2310],
16	evidenced	VBN	O	evidence	dep	15	SENT_24	[p2l1184t2243r1510b2297],
17	statins-intolerance	NN	O	statins-intolerance	nsubj	20	SENT_24	[p2l1540t2243r2145b2297],
18	related	JJ	O	related	amod	19	SENT_24	[p2l13t2330r236b2384],
19	functional	JJ	O	functional	amod	20	SENT_24	[p2l279t2330r603b2384],
20	SNPs	NNS	O	snp	xcomp	16	SENT_24	[p2l646t2333r800b2384],
21	inducing	VBG	O	induce	partmod	20	SENT_24	[p2l844t2330r1124b2397],
22	variations	NNS	O	variation	dobj	21	SENT_24	[p2l1162t2331r1481b2384],
23	in	IN	O	in	_	0	SENT_24	[p2l1525t2331r1584b2383],
24	function	NN	O	function	nn	26	SENT_24	[p2l1626t2330r1894b2384],
25	and/or	NN	O	and/or	nn	26	SENT_24	[p2l1936t2330r2147b2397],
26	structure	NN	O	structure	prep_in	21	SENT_24	[p2l13t2424r304b2470],
27	of	IN	O	of	_	0	SENT_24	[p2l342t2416r408b2470],
28	the	DT	O	the	prep_of	26	SENT_24	[p2l437t2416r539b2470],
29	encoded	VBN	O	encode	partmod	28	SENT_24	[p2l577t2416r846b2470],
30	product	NN	O	product	dobj	29	SENT_24	[p2l884t2416r1135b2484],
31	that	WDT	O	that	nsubj	33	SENT_24	[p2l1171t2416r1300b2470],
32	potentially	RB	O	potentially	advmod	33	SENT_24	[p2l1336t2416r1686b2484],
33	affect	VBP	O	affect	rcmod	30	SENT_24	[p2l1721t2416r1898b2470],
34	statins	NNS	O	statin	nn	35	SENT_24	[p2l1936t2417r2144b2470],
35	pharmacokinetics	NNS	O	pharmacokinetic	dobj	33	SENT_24	[p2l12t2503r584b2571],
36	and/or	JJ	O	and/or	amod	37	SENT_24	[p2l622t2503r834b2571],
37	pharmacodynamics	NNS	O	pharmacodynamic	prep_of	13	SENT_24	[p2l868t2503r1516b2571],
38	.	.	O	.	_	0	SENT_24	[p2l868t2503r1516b2571],

1	The	DT	O	the	det	2	SENT_25	[p2l1550t2503r1667b2557],
2	latter	JJ	O	latter	nsubj	3	SENT_25	[p2l1703t2503r1876b2557],
3	include	VBP	O	include	_	0	SENT_25	[p2l1911t2503r2145b2557],
4	alterations	NNS	O	alteration	dobj	3	SENT_25	[p2l12t2590r354b2644],
5	in	IN	O	in	_	0	SENT_25	[p2l409t2591r467b2644],
6	susceptible	JJ	O	susceptible	amod	7	SENT_25	[p2l521t2590r879b2658],
7	involved	JJ	O	involved	amod	8	SENT_25	[p2l933t2590r1208b2644],
8	targets	NNS	O	target	prep_in	3	SENT_25	[p2l1261t2598r1480b2658],
9	such	JJ	O	such	_	0	SENT_25	[p2l1535t2590r1680b2644],
10	as	IN	O	as	_	0	SENT_25	[p2l1733t2606r1794b2645],
11	muscular	JJ	O	muscular	amod	13	SENT_25	[p2l1849t2590r2147b2644],
12	metabolism	NN	O	metabolism	nn	13	SENT_25	[p2l13t2678r393b2732],
13	[	NN	O	[	prep_such_as	8	SENT_25	[p2l433t2677r595b2745],
14	4	CD	NUMBER	4	num	15	SENT_25	[p2l433t2677r595b2745],
15	—	NN	O	—	dep	13	SENT_25	[p2l433t2677r595b2745],
16	7	CD	NUMBER	7	num	17	SENT_25	[p2l433t2677r595b2745],
17	]	NN	O	]	dep	15	SENT_25	[p2l433t2677r595b2745],
18	although	IN	O	although	mark	20	SENT_25	[p2l636t2678r921b2745],
19	not	RB	O	not	neg	20	SENT_25	[p2l959t2686r1064b2732],
20	evidenced	VBN	O	evidence	advcl	3	SENT_25	[p2l1101t2678r1426b2732],
21	in	IN	O	in	_	0	SENT_25	[p2l1465t2678r1524b2731],
22	the	DT	O	the	det	24	SENT_25	[p2l1561t2678r1662b2732],
23	genome-wide	JJ	O	genome-wide	amod	24	SENT_25	[p2l1699t2678r2145b2745],
24	evaluation	NN	O	evaluation	prep_in	20	SENT_25	[p2l12t2765r349b2819],
25	of	IN	O	of	_	0	SENT_25	[p2l375t2765r441b2819],
26	SEARCH	NN	O	search	prep_of	24	SENT_25	[p2l460t2767r715b2819],
27	[	CD	NUMBER	[	number	28	SENT_25	[p2l745t2765r844b2832],
28	3	CD	NUMBER	3	num	29	SENT_25	[p2l745t2765r844b2832],
29	]	NN	O	]	dobj	20	SENT_25	[p2l745t2765r844b2832],
30	.	.	O	.	_	0	SENT_25	[p2l745t2765r844b2832],

1	Extraction	NN	O	extraction	nsubjpass	12	SENT_26	[p2l871t2766r1201b2819],
2	of	IN	O	of	_	0	SENT_26	[p2l1226t2765r1292b2819],
3	DNA	NN	MISC	dna	nn	6	SENT_26	[p2l1310t2767r1457b2819],
4	and	CC	O	and	_	0	SENT_26	[p2l1480t2765r1595b2819],
5	technical	JJ	O	technical	nn	6	SENT_26	[p2l1621t2765r1911b2819],
6	equipments	NNS	O	equipment	prep_of	1	SENT_26	[p2l1938t2766r2144b2832, p2l13t2860r209b2906],
7	for	IN	O	for	_	0	SENT_26	[p2l233t2852r322b2906],
8	PCR	NN	O	pcr	prep_for	6	SENT_26	[p2l343t2855r466b2906],
9	were	VBD	O	be	auxpass	12	SENT_26	[p2l484t2868r644b2906],
10	as	RB	O	as	advmod	11	SENT_26	[p2l667t2868r728b2906],
11	previously	RB	DATE	previously	advmod	12	SENT_26	[p2l752t2852r1090b2919],
12	described	VBN	O	describe	_	0	SENT_26	[p2l1111t2852r1419b2906],
13	[	NN	O	[	nn	15	SENT_26	[p2l1446t2852r1544b2919],
14	8	CD	NUMBER	8	num	15	SENT_26	[p2l1446t2852r1544b2919],
15	]	NN	O	]	dobj	12	SENT_26	[p2l1446t2852r1544b2919],
16	.	.	O	.	_	0	SENT_26	[p2l1446t2852r1544b2919],

1	In	IN	O	in	_	0	SENT_27	[p2l114t2941r174b2992],
2	this	DT	O	this	det	3	SENT_27	[p2l202t2938r318b2992],
3	setting	NN	O	setting	prep_in	13	SENT_27	[p2l349t2939r581b3006],
4	,	,	O	,	_	0	SENT_27	[p2l349t2939r581b3006],
5	among	IN	O	among	_	0	SENT_27	[p2l612t2954r831b3006],
6	preliminary	JJ	O	preliminary	amod	7	SENT_27	[p2l859t2938r1239b3006],
7	data	NNS	O	datum	prep_among	13	SENT_27	[p2l1266t2938r1418b3000],
8	,	,	O	,	_	0	SENT_27	[p2l1266t2938r1418b3000],
9	our	PRP$	O	we	poss	10	SENT_27	[p2l1448t2954r1556b2992],
10	interest	NN	O	interest	nsubjpass	13	SENT_27	[p2l1584t2939r1830b2992],
11	has	VBZ	O	have	aux	13	SENT_27	[p2l1858t2938r1962b2992],
12	been	VBN	O	be	auxpass	13	SENT_27	[p2l1992t2938r2146b2992],
13	focused	VBN	O	focus	_	0	SENT_27	[p2l13t3025r257b3079],
14	in	IN	O	in	_	0	SENT_27	[p2l298t3026r356b3079],
15	Caucasian	JJ	MISC	caucasian	amod	16	SENT_27	[p2l396t3026r715b3079],
16	subjects	NNS	O	subject	nsubj	32	SENT_27	[p2l755t3025r1013b3093],
17	(	JJ	O	(	amod	16	SENT_27	[p2l1054t3025r1363b3093],
18	referring	VBG	O	refer	prepc_in	13	SENT_27	[p2l1054t3025r1363b3093],
19	as	IN	O	as	_	0	SENT_27	[p2l1401t3041r1464b3079],
20	European	JJ	MISC	european	amod	22	SENT_27	[p2l1505t3029r1809b3093],
21	ancestry	NN	O	ancestry	nn	22	SENT_27	[p2l1849t3025r2145b3093],
22	)	NN	O	)	prep_as	18	SENT_27	[p2l1849t3025r2145b3093],
23	affected	VBN	O	affect	partmod	22	SENT_27	[p2l12t3112r266b3166],
24	by	IN	O	by	_	0	SENT_27	[p2l316t3112r393b3180],
25	familial	JJ	O	familial	amod	26	SENT_27	[p2l442t3112r682b3166],
26	hypercholesterolemia	NN	O	hypercholesterolemia	agent	23	SENT_27	[p2l733t3112r1436b3180],
27	treated	VBN	O	treat	partmod	26	SENT_27	[p2l1486t3112r1715b3166],
28	solely	RB	O	solely	advmod	27	SENT_27	[p2l1766t3112r1951b3180],
29	with	IN	O	with	_	0	SENT_27	[p2l1998t3112r2146b3166],
30	statins	NNS	O	statin	prep_with	27	SENT_27	[p2l13t3201r222b3254],
31	and	CC	O	and	_	0	SENT_27	[p2l263t3200r378b3254],
32	developing	VBG	O	develop	conj_and	18	SENT_27	[p2l419t3200r775b3267],
33	mild-myopathy	JJ	O	mild-myopathy	dobj	32	SENT_27	[p2l814t3200r1319b3267],
34	according	VBG	O	accord	_	0	SENT_27	[p2l1356t3200r1670b3267],
35	to	TO	O	to	prepc_according_to	32	SENT_27	[p2l1708t3208r1769b3254],
36	previously	RB	DATE	previously	advmod	37	SENT_27	[p2l1810t3200r2147b3267],
37	described	VBN	O	describe	amod	38	SENT_27	[p2l12t3287r320b3341],
38	criteria	NNS	O	criterion	pobj	32	SENT_27	[p2l344t3288r573b3341],
39	[	CD	NUMBER	[	number	40	SENT_27	[p2l598t3287r697b3354],
40	4	CD	NUMBER	4	num	41	SENT_27	[p2l598t3287r697b3354],
41	]	NN	O	]	dobj	18	SENT_27	[p2l598t3287r697b3354],
42	.	.	O	.	_	0	SENT_27	[p2l598t3287r697b3354],

1	Actually	RB	O	actually	advmod	4	SENT_28	[p2l111t3373r376b3441],
2	we	PRP	O	we	nsubj	4	SENT_28	[p2l409t3389r503b3427],
3	have	VBP	O	have	aux	4	SENT_28	[p2l539t3373r688b3427],
4	analyzed	VBN	O	analyze	dep	16	SENT_28	[p2l724t3373r1008b3441],
5	76	CD	NUMBER	76	num	6	SENT_28	[p2l1045t3376r1120b3427],
6	cases	NNS	O	case	dobj	4	SENT_28	[p2l1156t3389r1320b3427],
7	of	IN	O	of	_	0	SENT_28	[p2l1357t3373r1423b3427],
8	muscular	JJ	O	muscular	amod	9	SENT_28	[p2l1451t3373r1750b3427],
9	intolerance	NN	O	intolerance	prep_of	6	SENT_28	[p2l1784t3373r2145b3427],
10	out	IN	O	out	_	0	SENT_28	[p2l12t3468r117b3514],
11	of	IN	O	of	_	0	SENT_28	[p2l151t3460r217b3514],
12	88	CD	NUMBER	88	num	15	SENT_28	[p2l245t3463r319b3514],
13	potentially	RB	O	potentially	advmod	14	SENT_28	[p2l357t3460r706b3528],
14	eligible	JJ	O	eligible	amod	15	SENT_28	[p2l739t3460r971b3528],
15	subjects	NNS	O	subject	prep_out_of	16	SENT_28	[p2l1007t3460r1265b3528],
16	[	VBP	O	[	_	0	SENT_28	[p2l1305t3460r1403b3528],
17	46	CD	NUMBER	46	dobj	16	SENT_28	[p2l1305t3460r1403b3528],
18	treated	VBN	O	treat	partmod	17	SENT_28	[p2l1438t3460r1667b3514],
19	with	IN	O	with	_	0	SENT_28	[p2l1701t3460r1849b3514],
20	atorvastatin	NN	O	atorvastatin	prep_with	18	SENT_28	[p2l1884t3468r2145b3514, p2l12t3548r160b3601],
21	(	CD	NUMBER	(	number	22	SENT_28	[p2l176t3547r280b3614],
22	34	CD	NUMBER	34	num	23	SENT_28	[p2l176t3547r280b3614],
23	females	NNS	O	female	nsubj	16	SENT_28	[p2l296t3547r542b3601],
24	and	CC	O	and	_	0	SENT_28	[p2l559t3547r674b3601],
25	12	CD	NUMBER	12	num	26	SENT_28	[p2l695t3550r766b3601],
26	males	NNS	O	male	conj_and	23	SENT_28	[p2l785t3547r997b3615],
27	)	CD	NUMBER	)	dep	26	SENT_28	[p2l785t3547r997b3615],
28	and	CC	O	and	_	0	SENT_28	[p2l1013t3547r1129b3601],
29	thirty	CD	NUMBER	thirty	dep	26	SENT_28	[p2l1145t3547r1327b3615],
30	treated	VBN	O	treat	partmod	23	SENT_28	[p2l1341t3547r1570b3601],
31	with	IN	O	with	_	0	SENT_28	[p2l1585t3547r1733b3601],
32	rosuvastatin	NN	O	rosuvastatin	prep_with	30	SENT_28	[p2l1749t3548r2146b3601],
33	(	CD	NUMBER	(	number	34	SENT_28	[p2l12t3635r107b3702],
34	21	CD	NUMBER	21	dep	45	SENT_28	[p2l12t3635r107b3702],
35	females	NNS	O	female	dep	34	SENT_28	[p2l143t3634r389b3688],
36	and	CC	O	and	_	0	SENT_28	[p2l417t3634r533b3688],
37	nine	CD	NUMBER	nine	num	38	SENT_28	[p2l562t3635r699b3688],
38	males	NNS	O	male	conj_and	34	SENT_28	[p2l728t3634r955b3702],
39	)	RB	O	)	advmod	38	SENT_28	[p2l728t3634r955b3702],
40	,	,	O	,	_	0	SENT_28	[p2l728t3634r955b3702],
41	global	JJ	O	global	amod	42	SENT_28	[p2l982t3634r1176b3702],
42	mean	NN	O	mean	appos	38	SENT_28	[p2l1204t3650r1381b3688],
43	age	NN	O	age	dep	45	SENT_28	[p2l1408t3650r1515b3702],
44	47.5	CD	NUMBER	47.5	num	43	SENT_28	[p2l1541t3637r1674b3689],
45	i	FW	O	i	dep	48	SENT_28	[p2l1694t3642r1739b3688],
46	5.8	CD	DURATION	5.8	num	47	SENT_28	[p2l1758t3637r1848b3689],
47	years	NNS	NUMBER	year	dep	45	SENT_28	[p2l1864t3634r2055b3702],
48	]	CD	NUMBER	]	dep	51	SENT_28	[p2l1864t3634r2055b3702],
49	of	IN	O	of	_	0	SENT_28	[p2l2087t3634r2153b3689],
50	whom	WP	O	whom	prep_of	48	SENT_28	[p2l10t3722r216b3776],
51	56	CD	NUMBER	56	dep	32	SENT_28	[p2l241t3724r316b3776],
52	with	IN	O	with	_	0	SENT_28	[p2l339t3722r487b3776],
53	previous	JJ	O	previous	amod	55	SENT_28	[p2l511t3722r786b3789],
54	statin	NN	O	statin	nn	55	SENT_28	[p2l812t3722r991b3776],
55	withdrawal	NN	O	withdrawal	prep_with	51	SENT_28	[p2l1013t3722r1385b3776],
56	and	CC	O	and	_	0	SENT_28	[p2l1410t3722r1526b3776],
57	20	CD	NUMBER	20	conj_and	55	SENT_28	[p2l1551t3724r1627b3776],
58	who	WP	O	who	nsubj	59	SENT_28	[p2l1650t3722r1789b3776],
59	developed	VBD	O	develop	rcmod	32	SENT_28	[p2l1814t3722r2145b3789],
60	myopathy	NN	O	myopathy	dobj	59	SENT_28	[p3l13t17r339b84],
61	during	IN	O	during	_	0	SENT_28	[p3l360t17r571b84],
62	the	DT	O	the	det	65	SENT_28	[p3l591t17r692b71],
63	ongoing	JJ	O	ongoing	amod	65	SENT_28	[p3l715t18r974b84],
64	observational	JJ	O	observational	amod	65	SENT_28	[p3l995t17r1430b71],
65	period	NN	O	period	prep_during	59	SENT_28	[p3l1452t17r1674b84],
66	.	.	O	.	_	0	SENT_28	[p3l1452t17r1674b84],

1	The	DT	O	the	det	3	SENT_29	[p3l1694t17r1811b71],
2	evaluated	VBN	O	evaluate	amod	3	SENT_29	[p3l1834t17r2145b71],
3	subjects	NNS	O	subject	nsubj	5	SENT_29	[p3l13t103r271b171],
4	were	VBD	O	be	aux	5	SENT_29	[p3l292t119r452b157],
5	coming	VBG	O	come	_	0	SENT_29	[p3l475t104r712b171],
6	from	IN	O	from	_	0	SENT_29	[p3l733t103r886b157],
7	46	CD	NUMBER	46	num	9	SENT_29	[p3l905t106r984b157],
8	unrelated	JJ	O	unrelated	amod	9	SENT_29	[p3l1006t103r1315b157],
9	families	NNS	O	family	prep_from	5	SENT_29	[p3l1338t103r1588b157],
10	thus	RB	O	thus	advmod	11	SENT_29	[p3l1611t103r1748b157],
11	considering	VBG	O	consider	xcomp	5	SENT_29	[p3l1771t103r2147b171],
12	a	DT	O	a	det	13	SENT_29	[p3l12t206r44b244],
13	median	NN	O	median	dobj	11	SENT_29	[p3l71t190r311b244],
14	of	IN	O	of	_	0	SENT_29	[p3l337t190r403b244],
15	1.7	CD	NUMBER	1.7	num	16	SENT_29	[p3l426t193r514b245],
16	subjects	NNS	O	subject	prep_of	13	SENT_29	[p3l543t190r801b258],
17	per	IN	O	per	_	0	SENT_29	[p3l824t206r929b258],
18	family	NN	O	family	prep_per	16	SENT_29	[p3l952t190r1155b258],
19	enrolled	VBN	O	enrol	partmod	18	SENT_29	[p3l1180t190r1444b244],
20	in	IN	O	in	_	0	SENT_29	[p3l1472t191r1531b244],
21	the	DT	O	the	det	22	SENT_29	[p3l1557t190r1658b244],
22	study	NN	O	study	prep_in	19	SENT_29	[p3l1686t190r1863b258],
23	in	IN	O	in	_	0	SENT_29	[p3l1889t191r1947b244],
24	order	NN	O	order	prep_in	22	SENT_29	[p3l1973t190r2147b244],
25	to	TO	O	to	aux	26	SENT_29	[p3l12t285r73b331],
26	reduce	VB	O	reduce	xcomp	19	SENT_29	[p3l98t277r313b331],
27	the	DT	O	the	det	29	SENT_29	[p3l337t277r438b331],
28	possible	JJ	O	possible	amod	29	SENT_29	[p3l463t277r722b345],
29	effect	NN	O	effect	dobj	26	SENT_29	[p3l746t277r924b331],
30	of	IN	O	of	_	0	SENT_29	[p3l946t277r1013b331],
31	clustering	NN	O	clustering	prep_of	29	SENT_29	[p3l1029t277r1348b345],
32	in	IN	O	in	_	0	SENT_29	[p3l1371t278r1430b331],
33	this	DT	O	this	det	35	SENT_29	[p3l1453t277r1569b331],
34	speciﬁc	NN	O	speciﬁc	nn	35	SENT_29	[p3l1595t277r1833b345],
35	cohort	NN	O	cohort	prep_in	26	SENT_29	[p3l1856t277r2064b331],
36	of	IN	O	of	_	0	SENT_29	[p3l2087t277r2153b331],
37	familial	JJ	O	familial	amod	38	SENT_29	[p3l13t364r253b418],
38	hypercholesterolemia	NN	O	hypercholesterolemia	prep_of	35	SENT_29	[p3l276t364r995b432],
39	.	.	O	.	_	0	SENT_29	[p3l276t364r995b432],

1	The	DT	O	the	det	5	SENT_30	[p3l111t452r227b506],
2	multivariate	JJ	O	multivariate	amod	5	SENT_30	[p3l274t452r669b506],
3	logistic	JJ	O	logistic	amod	5	SENT_30	[p3l717t452r945b519],
4	regression	NN	O	regression	nn	5	SENT_30	[p3l991t452r1323b519],
5	analysis	NN	O	analysis	nsubj	6	SENT_30	[p3l1368t452r1622b519],
6	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_30	[p3l1669t451r1997b506],
7	the	DT	O	the	det	8	SENT_30	[p3l2044t452r2145b506],
8	prevalence	NN	O	prevalence	dep	42	SENT_30	[p3l12t539r361b606],
9	of	IN	O	of	_	0	SENT_30	[p3l405t539r471b593],
10	female	JJ	O	female	amod	12	SENT_30	[p3l507t539r721b593],
11	sex	NN	O	sex	nn	12	SENT_30	[p3l765t554r869b593],
12	(	NN	O	(	prep_of	8	SENT_30	[p3l910t539r1010b606],
13	55	CD	NUMBER	55	num	14	SENT_30	[p3l910t539r1010b606],
14	cases	NNS	O	case	dep	23	SENT_30	[p3l1056t555r1236b601],
15	,	,	O	,	_	0	SENT_30	[p3l1056t555r1236b601],
16	O.R.	NNP	O	O.R.	appos	14	SENT_30	[p3l1281t542r1401b593],
17	3.1	CD	NUMBER	3.1	num	16	SENT_30	[p3l1444t542r1554b601],
18	,	,	O	,	_	0	SENT_30	[p3l1444t542r1554b601],
19	95	CD	PERCENT	95	num	20	SENT_30	[p3l1598t542r1719b593],
20	%	NN	PERCENT	%	appos	14	SENT_30	[p3l1598t542r1719b593],
21	C.l.	NNP	O	C.l.	dep	23	SENT_30	[p3l1762t542r1853b593],
22	1.9-4	CD	NUMBER	1.9-4	num	23	SENT_30	[p3l1900t542r2144b601],
23	.9	CD	NUMBER	.9	dep	29	SENT_30	[p3l1900t542r2144b601],
24	,	,	O	,	_	0	SENT_30	[p3l1900t542r2144b601],
25	beta-coefﬁcient	JJ	O	beta-coefﬁcient	amod	26	SENT_30	[p3l11t625r517b679],
26	1.96	CD	NUMBER	1.96	appos	23	SENT_30	[p3l543t628r689b688],
27	,	,	O	,	_	0	SENT_30	[p3l543t628r689b688],
28	p	NN	O	p	appos	23	SENT_30	[p3l708t641r747b693],
29	<	JJR	O	<	dep	8	SENT_30	[p3l764t637r796b672],
30	0.001	CD	NUMBER	0.001	num	31	SENT_30	[p3l814t625r1014b692],
31	)	NN	O	)	dep	29	SENT_30	[p3l814t625r1014b692],
32	and	CC	O	and	_	0	SENT_30	[p3l1038t625r1154b679],
33	of	IN	O	of	_	0	SENT_30	[p3l1178t625r1244b679],
34	higher	JJR	O	higher	amod	36	SENT_30	[p3l1260t625r1468b693],
35	statin	NN	O	statin	nn	36	SENT_30	[p3l1490t626r1669b679],
36	dosage	NN	O	dosage	prep_of	38	SENT_30	[p3l1693t625r1912b693],
37	(	CD	NUMBER	(	number	38	SENT_30	[p3l1937t625r2145b693],
38	24/30	CD	NUMBER	24/30	conj_and	8	SENT_30	[p3l1937t625r2145b693],
39	rosuvastatin	NN	O	rosuvastatin	dep	42	SENT_30	[p3l13t713r409b766],
40	20	CD	NUMBER	20	num	39	SENT_30	[p3l433t715r510b766],
41	mg	NN	O	mg	nn	42	SENT_30	[p3l527t728r626b780],
42	O.R.	NN	O	o.r.	dep	49	SENT_30	[p3l650t715r771b767],
43	4.1	CD	NUMBER	4.1	dep	42	SENT_30	[p3l794t715r905b775],
44	,	,	O	,	_	0	SENT_30	[p3l794t715r905b775],
45	95	CD	PERCENT	95	number	46	SENT_30	[p3l931t715r1052b766],
46	%	NN	PERCENT	%	amod	47	SENT_30	[p3l931t715r1052b766],
47	C.I.	NNP	O	C.I.	appos	43	SENT_30	[p3l1077t715r1168b767],
48	2.2-6	CD	NUMBER	2.2-6	num	49	SENT_30	[p3l1193t715r1441b775],
49	.9	CD	NUMBER	.9	dep	67	SENT_30	[p3l1193t715r1441b775],
50	,	,	O	,	_	0	SENT_30	[p3l1193t715r1441b775],
51	beta-coefﬁcient	JJ	O	beta-coefﬁcient	amod	52	SENT_30	[p3l1466t712r1972b766],
52	2.57	CD	NUMBER	2.57	appos	49	SENT_30	[p3l1995t715r2144b775],
53	,	,	O	,	_	0	SENT_30	[p3l1995t715r2144b775],
54	p	NN	O	p	dep	55	SENT_30	[p3l7t815r46b867],
55	<	JJR	O	<	appos	49	SENT_30	[p3l62t812r95b846],
56	0.0001	CD	NUMBER	0.0001	dep	55	SENT_30	[p3l113t802r347b862],
57	;	:	O	;	_	0	SENT_30	[p3l113t802r347b862],
58	14/46	CD	NUMBER	14/46	num	59	SENT_30	[p3l375t799r554b867],
59	atorvastatin	NN	O	atorvastatin	dep	55	SENT_30	[p3l574t800r960b853],
60	20	CD	NUMBER	20	num	61	SENT_30	[p3l979t802r1055b853],
61	mg	NN	O	mg	dep	59	SENT_30	[p3l1072t815r1185b867],
62	,	,	O	,	_	0	SENT_30	[p3l1072t815r1185b867],
63	26/46	CD	NUMBER	26/46	num	64	SENT_30	[p3l1205t799r1388b867],
64	atorvastatin	NN	O	atorvastatin	appos	49	SENT_30	[p3l1407t800r1794b853],
65	40	CD	NUMBER	40	num	67	SENT_30	[p3l1811t802r1889b853],
66	mg	NN	O	mg	nn	67	SENT_30	[p3l1906t815r2005b867],
67	O.R.	NN	O	o.r.	dep	74	SENT_30	[p3l2023t802r2144b854],
68	3.3	CD	NUMBER	3.3	dep	67	SENT_30	[p3l11t889r121b949],
69	,	,	O	,	_	0	SENT_30	[p3l11t889r121b949],
70	95	CD	PERCENT	95	number	71	SENT_30	[p3l146t889r267b941],
71	%	NN	PERCENT	%	amod	72	SENT_30	[p3l146t889r267b941],
72	C.I.	NNP	O	C.I.	appos	68	SENT_30	[p3l290t889r382b941],
73	1.7-5	CD	NUMBER	1.7-5	num	74	SENT_30	[p3l410t889r654b949],
74	.6	CD	NUMBER	.6	dep	80	SENT_30	[p3l410t889r654b949],
75	,	,	O	,	_	0	SENT_30	[p3l410t889r654b949],
76	beta-coefﬁcient	JJ	O	beta-coefﬁcient	amod	77	SENT_30	[p3l679t886r1184b941],
77	3.81	CD	NUMBER	3.81	appos	74	SENT_30	[p3l1206t889r1357b949],
78	,	,	O	,	_	0	SENT_30	[p3l1206t889r1357b949],
79	p	NN	O	p	appos	74	SENT_30	[p3l1377t902r1415b954],
80	<	JJR	O	<	dep	6	SENT_30	[p3l1432t899r1464b933],
81	0.001	CD	NUMBER	0.001	num	82	SENT_30	[p3l1482t887r1682b954],
82	)	NN	O	)	dep	80	SENT_30	[p3l1482t887r1682b954],
83	in	IN	O	in	_	0	SENT_30	[p3l1707t887r1766b940],
84	association	NN	O	association	prep_in	82	SENT_30	[p3l1789t887r2146b941],
85	with	IN	O	with	_	0	SENT_30	[p3l10t974r158b1028],
86	muscular	JJ	O	muscular	amod	87	SENT_30	[p3l179t974r477b1028],
87	intolerance	NN	O	intolerance	prep_with	84	SENT_30	[p3l495t974r857b1028],
88	(	CD	NUMBER	(	num	90	SENT_30	[p3l878t974r1100b1041],
89	whole	JJ	O	whole	amod	90	SENT_30	[p3l878t974r1100b1041],
90	cohort	NN	O	cohort	dobj	6	SENT_30	[p3l1120t974r1328b1028],
91	86	CD	PERCENT	86	num	92	SENT_30	[p3l1347t976r1468b1028],
92	%	NN	PERCENT	%	dep	90	SENT_30	[p3l1347t976r1468b1028],
93	both	CC	O	both	preconj	90	SENT_30	[p3l1487t974r1633b1028],
94	myalgia	NN	O	myalgium	conj	90	SENT_30	[p3l1653t974r1906b1041],
95	and	CC	O	and	_	0	SENT_30	[p3l1925t974r2041b1028],
96	CK	NN	O	ck	nn	98	SENT_30	[p3l2062t976r2147b1028],
97	increase	NN	O	increase	nn	98	SENT_30	[p3l13t1061r317b1128],
98	)	NN	O	)	conj_and	94	SENT_30	[p3l13t1061r317b1128],
99	.	.	O	.	_	0	SENT_30	[p3l13t1061r317b1128],

1	Interestingly	RB	O	interestingly	dep	106	SENT_31	[p3l114t1147r537b1215],
2	,	,	O	,	_	0	SENT_31	[p3l114t1147r537b1215],
3	in	IN	O	in	dep	106	SENT_31	[p3l579t1148r639b1201],
4	the	DT	O	the	dep	106	SENT_31	[p3l678t1147r779b1201],
5	cohort	NN	O	cohort	dep	106	SENT_31	[p3l820t1147r1028b1201],
6	of	IN	O	of	dep	106	SENT_31	[p3l1068t1147r1134b1201],
7	both	CC	O	both	dep	106	SENT_31	[p3l1165t1147r1312b1201],
8	intolerant	JJ	O	intolerant	dep	106	SENT_31	[p3l1352t1147r1671b1201],
9	and	CC	O	and	dep	106	SENT_31	[p3l1710t1147r1826b1201],
10	matched	VBN	O	match	dep	106	SENT_31	[p3l1867t1147r2145b1201],
11	tolerant	JJ	O	tolerant	dep	106	SENT_31	[p3l12t1234r267b1288],
12	subjects	NNS	O	subject	dep	106	SENT_31	[p3l305t1234r579b1302],
13	,	,	O	,	_	0	SENT_31	[p3l305t1234r579b1302],
14	the	DT	O	the	dep	106	SENT_31	[p3l617t1234r718b1288],
15	selected	VBN	O	select	dep	106	SENT_31	[p3l757t1234r1017b1288],
16	genomic	JJ	O	genomic	dep	106	SENT_31	[p3l1054t1235r1329b1302],
17	study	NN	O	study	dep	106	SENT_31	[p3l1367t1234r1544b1302],
18	showed	VBD	O	show	dep	106	SENT_31	[p3l1581t1234r1828b1288],
19	no	DT	O	no	dep	106	SENT_31	[p3l1867t1250r1944b1288],
20	association	NN	O	association	dep	106	SENT_31	[p3l1982t1250r2145b1288, p3l12t1323r229b1377],
21	between	IN	O	between	dep	106	SENT_31	[p3l266t1322r544b1377],
22	the	DT	O	the	dep	106	SENT_31	[p3l581t1322r682b1377],
23	C-allele	NN	O	c-allele	dep	106	SENT_31	[p3l722t1322r961b1377],
24	of	IN	O	of	dep	106	SENT_31	[p3l1000t1322r1066b1377],
25	rs4149056	NN	O	rs4149056	dep	106	SENT_31	[p3l1097t1325r1437b1377],
26	SNP	NN	ORGANIZATION	snp	dep	106	SENT_31	[p3l1477t1325r1601b1377],
27	in	IN	O	in	dep	106	SENT_31	[p3l1639t1323r1698b1376],
28	the	DT	O	the	dep	106	SENT_31	[p3l1735t1323r1836b1377],
29	SLCO1B1	NN	O	slco1b1	dep	106	SENT_31	[p3l1872t1325r2138b1377],
30	(	CD	NUMBER	(	dep	106	SENT_31	[p3l12t1409r101b1477],
31	*	NN	O	*	dep	106	SENT_31	[p3l12t1409r101b1477],
32	5	CD	NUMBER	5	dep	106	SENT_31	[p3l12t1409r101b1477],
33	variant	JJ	O	variant	dep	106	SENT_31	[p3l133t1410r386b1477],
34	)	NN	O	)	dep	106	SENT_31	[p3l133t1410r386b1477],
35	and	CC	O	and	dep	106	SENT_31	[p3l418t1410r534b1464],
36	myopathy	NN	O	myopathy	dep	106	SENT_31	[p3l567t1410r894b1477],
37	in	IN	O	in	dep	106	SENT_31	[p3l924t1410r983b1463],
38	rosuvastatin	NN	O	rosuvastatin	dep	106	SENT_31	[p3l1015t1410r1673b1464],
39	—	NN	O	—	dep	106	SENT_31	[p3l1015t1410r1673b1464],
40	treated	JJ	O	treated	dep	106	SENT_31	[p3l1015t1410r1673b1464],
41	subjects	NNS	O	subject	dep	106	SENT_31	[p3l1706t1410r1964b1477],
42	(	JJ	O	(	dep	106	SENT_31	[p3l1997t1410r2144b1477],
43	O.R.	NNP	O	O.R.	dep	106	SENT_31	[p3l1997t1410r2144b1477],
44	0.65	CD	NUMBER	0.65	dep	106	SENT_31	[p3l12t1500r161b1559],
45	,	,	O	,	_	0	SENT_31	[p3l12t1500r161b1559],
46	95	CD	PERCENT	95	dep	106	SENT_31	[p3l203t1500r323b1551],
47	%	NN	PERCENT	%	dep	106	SENT_31	[p3l203t1500r323b1551],
48	C.I.	NNP	O	C.I.	dep	106	SENT_31	[p3l363t1500r454b1551],
49	0.24-1	CD	NUMBER	0.24-1	dep	106	SENT_31	[p3l495t1500r824b1559],
50	.01	CD	NUMBER	.01	dep	106	SENT_31	[p3l495t1500r824b1559],
51	,	,	O	,	_	0	SENT_31	[p3l495t1500r824b1559],
52	beta-coefﬁcient	JJ	O	beta-coefﬁcient	dep	106	SENT_31	[p3l865t1497r1371b1551],
53	0.29	CD	NUMBER	0.29	dep	106	SENT_31	[p3l1409t1500r1558b1559],
54	,	,	O	,	_	0	SENT_31	[p3l1409t1500r1558b1559],
55	p	NN	O	p	dep	106	SENT_31	[p3l1594t1497r1900b1564],
56	=	JJ	O	=	dep	106	SENT_31	[p3l1594t1497r1900b1564],
57	0.099	CD	NUMBER	0.099	dep	106	SENT_31	[p3l1594t1497r1900b1564],
58	)	CD	NUMBER	)	dep	106	SENT_31	[p3l1594t1497r1900b1564],
59	or	CC	O	or	dep	106	SENT_31	[p3l1941t1513r2006b1551],
60	the	DT	O	the	dep	106	SENT_31	[p3l2044t1497r2145b1551],
61	protective	JJ	O	protective	dep	106	SENT_31	[p3l12t1585r338b1651],
62	G	NN	O	g	dep	106	SENT_31	[p3l371t1587r416b1638],
63	variant	NN	O	variant	dep	106	SENT_31	[p3l447t1585r675b1638],
64	of	IN	O	of	dep	106	SENT_31	[p3l707t1584r773b1638],
65	rs2306283	NN	O	rs2306283	dep	106	SENT_31	[p3l799t1587r1136b1638],
66	(	CD	NUMBER	(	dep	106	SENT_31	[p3l1172t1584r1319b1651],
67	O.R.	NNP	O	O.R.	dep	106	SENT_31	[p3l1172t1584r1319b1651],
68	0.49	CD	NUMBER	0.49	dep	106	SENT_31	[p3l1353t1587r1502b1646],
69	,	,	O	,	_	0	SENT_31	[p3l1353t1587r1502b1646],
70	95	CD	PERCENT	95	dep	106	SENT_31	[p3l1537t1587r1657b1638],
71	%	NN	PERCENT	%	dep	106	SENT_31	[p3l1537t1587r1657b1638],
72	C.I.	NNP	O	C.I.	dep	106	SENT_31	[p3l1691t1587r1782b1638],
73	0.21-0	CD	NUMBER	0.21-0	dep	106	SENT_31	[p3l1815t1587r2144b1646],
74	.97	CD	NUMBER	.97	dep	106	SENT_31	[p3l1815t1587r2144b1646],
75	,	,	O	,	_	0	SENT_31	[p3l1815t1587r2144b1646],
76	beta-coefﬁcient	JJ	O	beta-coefﬁcient	dep	106	SENT_31	[p3l11t1670r517b1724],
77	0.26	CD	NUMBER	0.26	dep	106	SENT_31	[p3l563t1673r712b1732],
78	,	,	O	,	_	0	SENT_31	[p3l563t1673r712b1732],
79	p	NN	O	p	dep	106	SENT_31	[p3l754t1670r1060b1738],
80	=	JJ	O	=	dep	106	SENT_31	[p3l754t1670r1060b1738],
81	0.106	CD	NUMBER	0.106	dep	106	SENT_31	[p3l754t1670r1060b1738],
82	)	CD	NUMBER	)	dep	106	SENT_31	[p3l754t1670r1060b1738],
83	whereas	IN	O	whereas	dep	106	SENT_31	[p3l1105t1670r1375b1724],
84	it	PRP	O	it	dep	106	SENT_31	[p3l1424t1671r1467b1724],
85	was	VBD	O	be	dep	106	SENT_31	[p3l1510t1686r1635b1724],
86	conﬁrmed	VBN	O	conﬁrmed	dep	106	SENT_31	[p3l1683t1670r2010b1724],
87	for	IN	O	for	dep	106	SENT_31	[p3l2058t1670r2147b1724],
88	atorvastatin	NN	O	atorvastatin	dep	106	SENT_31	[p3l12t1758r398b1811],
89	(	CD	NUMBER	(	dep	106	SENT_31	[p3l451t1757r599b1824],
90	O.R.	NNP	O	O.R.	dep	106	SENT_31	[p3l451t1757r599b1824],
91	2.7	CD	NUMBER	2.7	dep	106	SENT_31	[p3l653t1760r762b1820],
92	,	,	O	,	_	0	SENT_31	[p3l653t1760r762b1820],
93	95	CD	PERCENT	95	dep	106	SENT_31	[p3l816t1760r937b1811],
94	%	NN	PERCENT	%	dep	106	SENT_31	[p3l816t1760r937b1811],
95	C.I.	NNP	O	C.I.	dep	106	SENT_31	[p3l990t1760r1081b1812],
96	1.3-4	CD	NUMBER	1.3-4	dep	106	SENT_31	[p3l1139t1760r1383b1820],
97	.9	CD	NUMBER	.9	dep	106	SENT_31	[p3l1139t1760r1383b1820],
98	,	,	O	,	_	0	SENT_31	[p3l1139t1760r1383b1820],
99	beta-coefﬁcient	JJ	O	beta-coefﬁcient	dep	106	SENT_31	[p3l1437t1757r1943b1811],
100	1.56	CD	NUMBER	1.56	dep	106	SENT_31	[p3l1998t1760r2144b1820],
101	,	,	O	,	_	0	SENT_31	[p3l1998t1760r2144b1820],
102	p	NN	O	p	dep	106	SENT_31	[p3l7t1860r46b1912],
103	<	JJR	O	<	dep	106	SENT_31	[p3l62t1857r95b1891],
104	0.001	CD	NUMBER	0.001	dep	106	SENT_31	[p3l113t1847r279b1899],
105	S1	NN	O	s1	dep	106	SENT_31	[p3l295t1845r328b1912],
106	+	CC	O	+	_	0	SENT_31	[p3l295t1845r328b1912],

1	On	IN	O	on	_	0	SENT_32	[p3l114t1934r202b1986],
2	the	DT	O	the	det	3	SENT_32	[p3l220t1932r321b1986],
3	contrary	NN	O	contrary	prep_on	8	SENT_32	[p3l340t1940r612b1999],
4	a	DT	O	a	det	6	SENT_32	[p3l629t1947r661b1986],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_32	[p3l680t1931r1013b1999],
6	association	NN	O	association	nsubjpass	8	SENT_32	[p3l1030t1932r1387b1986],
7	was	VBD	O	be	auxpass	8	SENT_32	[p3l1403t1947r1527b1986],
8	found	VBN	O	find	_	0	SENT_32	[p3l1547t1931r1731b1986],
9	in	IN	O	in	_	0	SENT_32	[p3l1751t1932r1810b1985],
10	intolerant	JJ	O	intolerant	amod	14	SENT_32	[p3l1828t1932r2147b1986],
11	rosuvastatin	NN	O	rosuvastatin	nn	14	SENT_32	[p3l13t2019r671b2073],
12	—	NN	O	—	nn	14	SENT_32	[p3l13t2019r671b2073],
13	treated	JJ	O	treated	amod	14	SENT_32	[p3l13t2019r671b2073],
14	subjects	NNS	O	subject	prep_in	8	SENT_32	[p3l704t2019r962b2086],
15	with	IN	O	with	_	0	SENT_32	[p3l994t2019r1141b2073],
16	the	DT	O	the	det	18	SENT_32	[p3l1172t2019r1274b2073],
17	rs4693075	NN	O	rs4693075	nn	18	SENT_32	[p3l1306t2022r1644b2073],
18	variant	NN	O	variant	prep_with	8	SENT_32	[p3l1677t2020r1905b2073],
19	within	IN	O	within	_	0	SENT_32	[p3l1934t2019r2146b2073],
20	the	DT	O	the	det	22	SENT_32	[p3l12t2105r113b2159],
21	COQ2	NN	O	coq2	nn	22	SENT_32	[p3l152t2108r321b2170],
22	gene	NN	O	gene	prep_within	8	SENT_32	[p3l358t2121r509b2173],
23	(	CD	NUMBER	(	num	24	SENT_32	[p3l546t2105r694b2172],
24	O.R.	NNP	O	O.R.	dep	22	SENT_32	[p3l546t2105r694b2172],
25	2.6	CD	NUMBER	2.6	num	24	SENT_32	[p3l732t2108r841b2168],
26	,	,	O	,	_	0	SENT_32	[p3l732t2108r841b2168],
27	95	CD	PERCENT	95	number	28	SENT_32	[p3l880t2108r1000b2159],
28	%	NN	PERCENT	%	amod	29	SENT_32	[p3l880t2108r1000b2159],
29	C.l.	NNP	O	C.l.	appos	22	SENT_32	[p3l1038t2108r1129b2160],
30	1.7-4	CD	NUMBER	1.7-4	num	31	SENT_32	[p3l1171t2108r1415b2167],
31	.4	CD	NUMBER	.4	dep	29	SENT_32	[p3l1171t2108r1415b2167],
32	,	,	O	,	_	0	SENT_32	[p3l1171t2108r1415b2167],
33	beta-coefﬁcient	JJ	O	beta-coefﬁcient	amod	37	SENT_32	[p3l1453t2105r1959b2159],
34	1.86	CD	NUMBER	1.86	tmod	33	SENT_32	[p3l1998t2108r2144b2167],
35	,	,	O	,	_	0	SENT_32	[p3l1998t2108r2144b2167],
36	p	NN	O	p	appos	34	SENT_32	[p3l7t2208r46b2260],
37	<	JJR	O	<	appos	22	SENT_32	[p3l62t2205r95b2239],
38	0.001	CD	NUMBER	0.001	num	39	SENT_32	[p3l113t2192r328b2259],
39	)	NN	O	)	dep	37	SENT_32	[p3l113t2192r328b2259],
40	.	.	O	.	_	0	SENT_32	[p3l113t2192r328b2259],

1	In	IN	O	in	_	0	SENT_33	[p3l349t2196r408b2246],
2	atorvastatin	NN	O	atorvastatin	prep_in	12	SENT_33	[p3l427t2192r1075b2246],
3	—	CD	NUMBER	—	num	5	SENT_33	[p3l427t2192r1075b2246],
4	treated	JJ	O	treated	amod	5	SENT_33	[p3l427t2192r1075b2246],
5	subjects	NNS	O	subject	dep	2	SENT_33	[p3l1096t2192r1354b2260],
6	the	DT	O	the	det	7	SENT_33	[p3l1373t2192r1474b2246],
7	association	NN	O	association	nsubj	12	SENT_33	[p3l1494t2193r1850b2246],
8	between	IN	O	between	_	0	SENT_33	[p3l1868t2192r2146b2246],
9	the	DT	O	the	det	11	SENT_33	[p3l12t2279r113b2333],
10	two	CD	NUMBER	two	num	11	SENT_33	[p3l134t2287r256b2333],
11	polymorphisms	NNS	O	polymorphism	prep_between	7	SENT_33	[p3l279t2279r782b2347],
12	recurred	VBD	O	recur	_	0	SENT_33	[p3l806t2279r1078b2333],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_33	[p3l1101t2279r1495b2347],
14	in	IN	O	in	_	0	SENT_33	[p3l1515t2280r1574b2333],
15	patients	NNS	O	patient	prep_in	12	SENT_33	[p3l1596t2280r1853b2347],
16	presenting	VBG	O	present	xcomp	12	SENT_33	[p3l1876t2287r2145b2347, p3l13t2367r111b2434],
17	with	IN	O	with	_	0	SENT_33	[p3l134t2366r283b2420],
18	both	CC	O	both	preconj	20	SENT_33	[p3l309t2366r454b2420],
19	muscular	JJ	O	muscular	amod	20	SENT_33	[p3l482t2366r780b2421],
20	symptoms	NNS	O	symptom	prep_with	16	SENT_33	[p3l806t2374r1140b2434],
21	and	CC	O	and	_	0	SENT_33	[p3l1168t2366r1283b2420],
22	CK	NN	O	ck	nn	23	SENT_33	[p3l1311t2369r1396b2420],
23	increase	NN	O	increase	conj_and	20	SENT_33	[p3l1422t2367r1685b2420],
24	(	CD	NUMBER	(	num	25	SENT_33	[p3l1712t2367r1859b2434],
25	O.R.	NNP	O	O.R.	dobj	16	SENT_33	[p3l1712t2367r1859b2434],
26	3.1	CD	NUMBER	3.1	num	25	SENT_33	[p3l1887t2369r1996b2429],
27	,	,	O	,	_	0	SENT_33	[p3l1887t2369r1996b2429],
28	95	CD	PERCENT	95	number	29	SENT_33	[p3l2024t2369r2146b2420],
29	%	NN	PERCENT	%	amod	30	SENT_33	[p3l2024t2369r2146b2420],
30	C.I.	NNP	O	C.I.	appos	25	SENT_33	[p3l12t2456r103b2508],
31	1.9-6	CD	NUMBER	1.9-6	num	32	SENT_33	[p3l130t2456r374b2516],
32	.4	CD	NUMBER	.4	dep	30	SENT_33	[p3l130t2456r374b2516],
33	,	,	O	,	_	0	SENT_33	[p3l130t2456r374b2516],
34	beta-coefﬁcient	JJ	O	beta-coefﬁcient	amod	35	SENT_33	[p3l397t2453r903b2508],
35	2.08	CD	NUMBER	2.08	appos	25	SENT_33	[p3l924t2456r1074b2516],
36	,	,	O	,	_	0	SENT_33	[p3l924t2456r1074b2516],
37	p	NN	O	p	dep	38	SENT_33	[p3l1092t2469r1130b2521],
38	<	JJR	O	<	appos	25	SENT_33	[p3l1147t2466r1180b2500],
39	0.001	CD	NUMBER	0.001	num	40	SENT_33	[p3l1197t2454r1413b2521],
40	)	NN	O	)	dep	38	SENT_33	[p3l1197t2454r1413b2521],
41	.	.	O	.	_	0	SENT_33	[p3l1197t2454r1413b2521],

1	Letter	NN	O	letter	_	0	SENT_34	[p3l372t2597r443b2618],
2	to	TO	O	to	dep	1	SENT_34	[p3l451t2599r473b2618],
3	the	DT	O	the	det	4	SENT_34	[p3l482t2596r519b2618],
4	Editor	NNP	O	Editor	pobj	2	SENT_34	[p3l526t2596r601b2618],
5	/	:	O	/	punct	1	SENT_34	[p3l605t2596r617b2623],
6	Atherosclerosis	NNP	O	Atherosclerosis	dep	9	SENT_34	[p3l621t2596r803b2618],
7	211	CD	NUMBER	211	dep	6	SENT_34	[p3l810t2597r853b2618],
8	(	CD	NUMBER	(	dep	9	SENT_34	[p3l864t2596r945b2623],
9	2010	CD	DATE	2010	dep	12	SENT_34	[p3l864t2596r945b2623],
10	)	CD	NUMBER	)	dep	9	SENT_34	[p3l864t2596r945b2623],
11	28-29	CD	NUMBER	28-29	num	12	SENT_34	[p3l952t2597r1029b2618],
12	29	CD	NUMBER	29	dep	1	SENT_34	[p3l1757t2597r1787b2618],

1	Allele	NN	O	allele	nn	2	SENT_35	[p3l117t2736r298b2790],
2	frequency	NN	O	frequency	nsubj	10	SENT_35	[p3l324t2735r646b2803],
3	for	IN	O	for	_	0	SENT_35	[p3l669t2735r758b2790],
4	COQ2	NN	O	coq2	nn	8	SENT_35	[p3l781t2738r951b2800],
5	and	CC	O	and	_	0	SENT_35	[p3l976t2736r1091b2790],
6	SLCO1	NN	O	slco1	nn	8	SENT_35	[p3l1114t2738r1300b2790],
7	B1	NN	O	b1	nn	8	SENT_35	[p3l1310t2739r1380b2789],
8	variants	NNS	O	variant	prep_for	2	SENT_35	[p3l1410t2736r1667b2790],
9	were	VBD	O	be	cop	10	SENT_35	[p3l1692t2751r1851b2790],
10	0.11	CD	NUMBER	0.11	_	0	SENT_35	[p3l1876t2738r2002b2790],
11	and	CC	O	and	_	0	SENT_35	[p3l2035t2736r2151b2790],
12	0.12	CD	NUMBER	0.12	conj_and	10	SENT_35	[p3l18t2826r167b2885],
13	,	,	O	,	_	0	SENT_35	[p3l18t2826r167b2885],
14	respectively	RB	O	respectively	advmod	10	SENT_35	[p3l185t2823r574b2890],
15	in	IN	O	in	_	0	SENT_35	[p3l589t2824r648b2876],
16	rosuvastatin	NN	O	rosuvastatin	nn	17	SENT_35	[p3l664t2823r1323b2877],
17	—	NN	O	—	prep_in	10	SENT_35	[p3l664t2823r1323b2877],
18	treated	VBN	O	treat	partmod	17	SENT_35	[p3l664t2823r1323b2877],
19	tolerant	JJ	O	tolerant	amod	20	SENT_35	[p3l1339t2823r1594b2877],
20	subjects	NNS	O	subject	dobj	18	SENT_35	[p3l1610t2823r1868b2890],
21	and	CC	O	and	_	0	SENT_35	[p3l1885t2823r2001b2877],
22	0.56	CD	NUMBER	0.56	dobj	18	SENT_35	[p3l2017t2826r2151b2877],
23	and	CC	O	and	_	0	SENT_35	[p3l18t2910r134b2964],
24	0.14	CD	NUMBER	0.14	conj_and	20	SENT_35	[p3l157t2913r306b2972],
25	,	,	O	,	_	0	SENT_35	[p3l157t2913r306b2972],
26	respectively	RB	O	respectively	advmod	22	SENT_35	[p3l330t2910r719b2978],
27	in	IN	O	in	_	0	SENT_35	[p3l740t2911r799b2964],
28	intolerant	JJ	O	intolerant	amod	29	SENT_35	[p3l822t2910r1140b2964],
29	patients	NNS	O	patient	prep_in	18	SENT_35	[p3l1161t2911r1435b2978],
30	.	.	O	.	_	0	SENT_35	[p3l1161t2911r1435b2978],

1	In	IN	O	in	_	0	SENT_36	[p3l120t3001r180b3051],
2	atorvastatin	NN	O	atorvastatin	nn	3	SENT_36	[p3l216t2997r864b3051],
3	—	NN	O	—	prep_in	16	SENT_36	[p3l216t2997r864b3051],
4	treated	VBN	O	treat	partmod	3	SENT_36	[p3l216t2997r864b3051],
5	asymptomatic	JJ	O	asymptomatic	amod	6	SENT_36	[p3l902t2998r1361b3065],
6	subjects	NNS	O	subject	dobj	4	SENT_36	[p3l1398t2997r1656b3065],
7	the	DT	O	the	det	9	SENT_36	[p3l1694t2997r1795b3051],
8	allele	NN	O	allele	nn	9	SENT_36	[p3l1832t2997r2000b3051],
9	frequency	NN	O	frequency	nsubj	16	SENT_36	[p3l2039t2997r2151b3051, p3l18t3100r251b3152],
10	for	IN	O	for	_	0	SENT_36	[p3l298t3084r388b3138],
11	COQ2	NN	O	coq2	nn	14	SENT_36	[p3l435t3087r605b3149],
12	and	CC	O	and	_	0	SENT_36	[p3l654t3084r770b3138],
13	SLCO1B1	NN	O	slco1b1	conj_and	11	SENT_36	[p3l817t3087r1083b3138],
14	variants	NNS	O	variant	prep_for	9	SENT_36	[p3l1137t3085r1395b3138],
15	were	VBD	O	be	cop	16	SENT_36	[p3l1443t3100r1603b3138],
16	0.12	CD	NUMBER	0.12	_	0	SENT_36	[p3l1653t3087r1784b3139],
17	and	CC	O	and	_	0	SENT_36	[p3l1836t3084r1951b3138],
18	0.13	CD	NUMBER	0.13	conj_and	16	SENT_36	[p3l2001t3087r2150b3147],
19	,	,	O	,	_	0	SENT_36	[p3l2001t3087r2150b3147],
20	respectively	RB	O	respectively	advmod	16	SENT_36	[p3l19t3171r408b3239],
21	in	IN	O	in	_	0	SENT_36	[p3l430t3172r489b3225],
22	tolerant	JJ	O	tolerant	amod	23	SENT_36	[p3l511t3171r767b3226],
23	subjects	NNS	O	subject	prep_in	16	SENT_36	[p3l789t3171r1047b3239],
24	and	CC	O	and	_	0	SENT_36	[p3l1071t3171r1187b3226],
25	0.24	CD	NUMBER	0.24	prep_in	16	SENT_36	[p3l1211t3174r1345b3226],
26	and	CC	O	and	_	0	SENT_36	[p3l1368t3171r1484b3226],
27	0.48	CD	NUMBER	0.48	conj_and	25	SENT_36	[p3l1508t3174r1657b3234],
28	,	,	O	,	_	0	SENT_36	[p3l1508t3174r1657b3234],
29	respectively	RB	O	respectively	advmod	16	SENT_36	[p3l1682t3171r2071b3239],
30	in	IN	O	in	_	0	SENT_36	[p3l2093t3172r2152b3225],
31	intolerant	JJ	O	intolerant	amod	32	SENT_36	[p3l18t3259r337b3313],
32	patients	NNS	O	patient	prep_in	16	SENT_36	[p3l359t3259r632b3326],
33	.	.	O	.	_	0	SENT_36	[p3l359t3259r632b3326],

1	Furthermore	RB	O	furthermore	advmod	13	SENT_37	[p3l120t3346r527b3400],
2	the	DT	O	the	det	4	SENT_37	[p3l548t3346r649b3400],
3	statistical	JJ	O	statistical	amod	4	SENT_37	[p3l672t3346r977b3400],
4	model	NN	O	model	nsubjpass	13	SENT_37	[p3l999t3346r1198b3400],
5	consisting	VBG	O	consist	partmod	4	SENT_37	[p3l1220t3347r1545b3413],
6	of	IN	O	of	_	0	SENT_37	[p3l1564t3346r1630b3400],
7	a	DT	O	a	det	9	SENT_37	[p3l1643t3361r1676b3400],
8	formal	JJ	O	formal	amod	9	SENT_37	[p3l1696t3346r1906b3400],
9	test	NN	O	test	prep_of	5	SENT_37	[p3l1926t3354r2045b3400],
10	for	IN	O	for	_	0	SENT_37	[p3l2064t3346r2153b3400],
11	interaction	NN	O	interaction	prep_for	9	SENT_37	[p3l18t3434r370b3487],
12	was	VBD	O	be	auxpass	13	SENT_37	[p3l401t3449r525b3487],
13	employed	VBN	O	employ	_	0	SENT_37	[p3l559t3433r876b3501],
14	to	TO	O	to	aux	15	SENT_37	[p3l909t3441r970b3487],
15	determine	VB	O	determine	xcomp	13	SENT_37	[p3l1003t3433r1335b3487],
16	the	DT	O	the	det	18	SENT_37	[p3l1368t3433r1469b3487],
17	putative	JJ	O	putative	amod	18	SENT_37	[p3l1502t3434r1767b3501],
18	interaction	NN	O	interaction	dobj	15	SENT_37	[p3l1800t3434r2152b3487],
19	for	IN	O	for	_	0	SENT_37	[p3l18t3520r108b3574],
20	each	DT	O	each	det	22	SENT_37	[p3l139t3520r284b3574],
21	single	JJ	O	single	amod	22	SENT_37	[p3l318t3520r503b3588],
22	variable	JJ	O	variable	prep_for	15	SENT_37	[p3l535t3520r792b3574],
23	including	VBG	O	include	_	0	SENT_37	[p3l826t3520r1127b3588],
24	genetic	JJ	O	genetic	amod	25	SENT_37	[p3l1157t3521r1390b3588],
25	proﬁle	NN	O	proﬁle	prep_including	22	SENT_37	[p3l1423t3520r1631b3588],
26	and	CC	O	and	_	0	SENT_37	[p3l1664t3520r1780b3574],
27	treatment	NN	O	treatment	prep_including	22	SENT_37	[p3l1813t3528r2150b3575],
28	.	.	O	.	_	0	SENT_37	[p3l1813t3528r2150b3575],

1	Brieﬂy	NNP	O	Brieﬂy	nsubj	23	SENT_38	[p3l18t3607r241b3675],
2	,	,	O	,	_	0	SENT_38	[p3l18t3607r241b3675],
3	starting	VBG	O	start	partmod	1	SENT_38	[p3l274t3608r521b3675],
4	from	IN	O	from	_	0	SENT_38	[p3l551t3607r704b3661],
5	logistic	JJ	O	logistic	amod	7	SENT_38	[p3l735t3607r964b3675],
6	regression	NN	O	regression	nn	7	SENT_38	[p3l995t3608r1327b3675],
7	analysis	NN	O	analysis	prep_from	3	SENT_38	[p3l1357t3607r1611b3675],
8	in	IN	O	in	_	0	SENT_38	[p3l1644t3608r1703b3661],
9	which	WDT	O	which	rel	14	SENT_38	[p3l1732t3607r1930b3661],
10	Y	NN	O	y	nsubj	14	SENT_38	[p3l1962t3611r2004b3661],
11	was	VBD	O	be	cop	14	SENT_38	[p3l2026t3623r2150b3662],
12	the	DT	O	the	det	14	SENT_38	[p3l17t3694r119b3749],
13	event	NN	O	event	nn	14	SENT_38	[p3l149t3702r326b3749],
14	ratio	NN	O	ratio	rcmod	7	SENT_38	[p3l355t3695r522b3757],
15	;	:	O	;	_	0	SENT_38	[p3l355t3695r522b3757],
16	the	DT	O	the	det	18	SENT_38	[p3l556t3694r657b3749],
17	variable	JJ	O	variable	amod	18	SENT_38	[p3l685t3694r942b3749],
18	X1	NN	O	x1	dep	14	SENT_38	[p3l965t3698r1034b3761],
19	and	CC	O	and	_	0	SENT_38	[p3l1073t3694r1189b3749],
20	X2	NN	O	x2	conj_and	18	SENT_38	[p3l1213t3698r1286b3761],
21	were	VBD	O	be	cop	23	SENT_38	[p3l1319t3710r1479b3748],
22	the	DT	O	the	det	23	SENT_38	[p3l1508t3694r1610b3749],
23	presence	NN	O	presence	_	0	SENT_38	[p3l1640t3710r1924b3762],
24	or	CC	O	or	_	0	SENT_38	[p3l1954t3710r2020b3748],
25	not	RB	O	not	conj_or	23	SENT_38	[p3l2048t3702r2153b3748],

1	(	NN	O	(	_	0	SENT_39	[p4l18t17r72b84],
2	1	CD	NUMBER	1	dep	1	SENT_39	[p4l18t17r72b84],
3	or	CC	O	or	_	0	SENT_39	[p4l113t32r179b71],
4	o	NN	O	o	nn	5	SENT_39	[p4l210t17r271b84],
5	)	NN	O	)	dep	1	SENT_39	[p4l210t17r271b84],
6	of	IN	O	of	_	0	SENT_39	[p4l305t16r371b71],
7	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_39	[p4l396t17r900b84],
8	and	CC	O	and	_	0	SENT_39	[p4l934t17r1050b71],
9	X3	NN	O	x3	prep_of	5	SENT_39	[p4l1077t20r1150b83],
10	the	DT	O	the	det	11	SENT_39	[p4l1188t17r1289b71],
11	combination	NN	O	combination	dep	5	SENT_39	[p4l1323t17r1744b71],
12	.	.	O	.	_	0	SENT_39	[p4l1323t17r1744b71],

1	The	DT	O	the	det	3	SENT_40	[p4l1775t17r1892b71],
2	simpliﬁed	JJ	O	simpliﬁed	amod	3	SENT_40	[p4l1926t17r2151b84, p4l18t104r136b158],
3	formula	NN	O	formulum	nsubj	6	SENT_40	[p4l154t104r406b158],
4	for	IN	O	for	_	0	SENT_40	[p4l424t104r513b158],
5	calculation	NN	O	calculation	prep_for	3	SENT_40	[p4l528t104r878b158],
6	was	VBD	O	be	ccomp	38	SENT_40	[p4l893t119r1038b158],
7	:	:	O	:	_	0	SENT_40	[p4l893t119r1038b158],
8	Y	NN	O	y	nsubjpass	25	SENT_40	[p4l1062t107r1145b157],
9	=	JJ	O	=	dep	25	SENT_40	[p4l1062t107r1145b157],
10	,60	CD	NUMBER	,60	tmod	9	SENT_40	[p4l1161t103r1235b173],
11	+	CC	O	+	_	0	SENT_40	[p4l1255t115r1288b149],
12	,81	CD	NUMBER	,81	num	13	SENT_40	[p4l1304t103r1449b173],
13	X1	NN	O	x1	nsubjpass	25	SENT_40	[p4l1304t103r1449b173],
14	+	CC	O	+	_	0	SENT_40	[p4l1475t115r1509b149],
15	,82	CD	NUMBER	,82	num	16	SENT_40	[p4l1525t103r1674b173],
16	X2	NN	O	x2	conj_+	13	SENT_40	[p4l1525t103r1674b173],
17	+	CC	O	+	rcmod	16	SENT_40	[p4l1696t115r1729b149],
18	,	,	O	,	_	0	SENT_40	[p4l1745t103r1893b173],
19	B3X3	NN	O	b3x3	nsubjpass	25	SENT_40	[p4l1745t103r1893b173],
20	and	CC	O	and	_	0	SENT_40	[p4l1916t104r2033b158],
21	the	DT	O	the	det	23	SENT_40	[p4l2050t104r2151b158],
22	null	JJ	O	null	amod	23	SENT_40	[p4l18t191r140b245],
23	hypothesis	NN	O	hypothesis	nsubjpass	25	SENT_40	[p4l175t191r522b259],
24	was	VBD	O	be	auxpass	25	SENT_40	[p4l556t207r680b245],
25	tested	VBN	O	test	parataxis	6	SENT_40	[p4l715t191r910b245],
26	as	IN	O	as	_	0	SENT_40	[p4l944t207r1006b245],
27	H0	NN	O	h0	prep_as	25	SENT_40	[p4l1039t190r1222b260],
28	:	:	O	:	_	0	SENT_40	[p4l1039t190r1222b260],
29	,	,	O	,	_	0	SENT_40	[p4l1039t190r1222b260],
30	B3	NN	O	b3	npadvmod	31	SENT_40	[p4l1039t190r1222b260],
31	=	JJ	O	=	amod	34	SENT_40	[p4l1245t194r1345b246],
32	o.	NNP	O	o.	nn	34	SENT_40	[p4l1245t194r1345b246],
33	Final	NNP	O	Final	nn	34	SENT_40	[p4l1381t191r1533b245],
34	validation	NN	O	validation	nsubjpass	38	SENT_40	[p4l1565t191r1889b245],
35	of	IN	O	of	_	0	SENT_40	[p4l1922t191r1988b245],
36	data	NNS	O	datum	prep_of	34	SENT_40	[p4l2015t191r2151b245],
37	was	VBD	O	be	auxpass	38	SENT_40	[p4l16t294r141b332],
38	assessed	VBN	O	assess	_	0	SENT_40	[p4l166t278r439b332],
39	by	IN	O	by	_	0	SENT_40	[p4l464t278r541b346],
40	a	DT	O	a	det	42	SENT_40	[p4l564t294r596b332],
41	resampling	NN	O	resampling	nn	42	SENT_40	[p4l621t278r981b346],
42	technique	NN	O	technique	agent	38	SENT_40	[p4l1003t278r1323b346],
43	(	CD	NUMBER	(	num	45	SENT_40	[p4l1348t278r1543b345],
44	exact	JJ	O	exact	amod	45	SENT_40	[p4l1348t278r1543b345],
45	tests	NNS	O	test	dep	42	SENT_40	[p4l1566t286r1713b332],
46	in	IN	O	in	_	0	SENT_40	[p4l1740t279r1798b332],
47	SPSS	NNP	ORGANIZATION	SPSS	prep_in	45	SENT_40	[p4l1823t281r1968b332],
48	2003	CD	DATE	2003	num	47	SENT_40	[p4l1993t281r2148b332],
49	module	NN	O	module	nn	50	SENT_40	[p4l19t365r286b433],
50	)	NN	O	)	dep	45	SENT_40	[p4l19t365r286b433],
51	and	CC	O	and	_	0	SENT_40	[p4l322t365r438b420],
52	discrimination	NN	O	discrimination	nn	53	SENT_40	[p4l473t365r942b420],
53	analysis	NN	O	analysis	conj_and	50	SENT_40	[p4l977t365r1230b433],
54	by	IN	O	by	_	0	SENT_40	[p4l1265t365r1342b433],
55	the	DT	O	the	det	56	SENT_40	[p4l1375t365r1476b419],
56	Hosmer	NNP	PERSON	Hosmer	agent	38	SENT_40	[p4l1511t365r2153b420],
57	.	.	O	.	_	0	SENT_40	[p4l1511t365r2153b420],

1	—	NN	O	—	_	0	SENT_41	[p4l1511t365r2153b420],
2	.	.	O	.	_	0	SENT_41	[p4l1511t365r2153b420],

1	Lemeshow	NN	MISC	lemeshow	nn	2	SENT_42	[p4l1511t365r2153b420],
2	method	NN	O	method	_	0	SENT_42	[p4l18t465r266b519],
3	[	CD	NUMBER	[	num	4	SENT_42	[p4l295t455r427b545],
4	Gfu	NN	O	gfu	npadvmod	5	SENT_42	[p4l295t455r427b545],
5	=	JJ	O	=	amod	2	SENT_42	[p4l453t494r499b511],
6	:	:	O	:	_	0	SENT_42	[p4l526t441r793b557],
7	:	:	O	:	_	0	SENT_42	[p4l526t441r793b557],
8	]	CD	NUMBER	]	dep	2	SENT_42	[p4l526t441r793b557],
9	1	CD	NUMBER	1	npadvmod	8	SENT_42	[p4l526t441r793b557],
10	:	:	O	:	_	0	SENT_42	[p4l526t441r793b557],
11	)	CD	NUMBER	)	dep	9	SENT_42	[p4l526t441r793b557],
12	1	CD	NUMBER	1	num	14	SENT_42	[p4l526t441r793b557],
13	(	NN	O	(	nn	14	SENT_42	[p4l526t441r793b557],
14	OJ	NN	ORGANIZATION	oj	rcmod	11	SENT_42	[p4l526t441r793b557],
15	-	:	O	-	_	0	SENT_42	[p4l526t441r793b557],
16	—	CD	NUMBER	—	number	17	SENT_42	[p4l819t500r861b503],
17	E	NN	O	e	dep	14	SENT_42	[p4l882t447r1153b545],
18	]	SYM	O	]	dep	14	SENT_42	[p4l882t447r1153b545],
19	-	:	O	-	_	0	SENT_42	[p4l882t447r1153b545],
20	)	NN	O	)	dep	14	SENT_42	[p4l882t447r1153b545],
21	2/E	NN	O	2/e	dep	20	SENT_42	[p4l882t447r1153b545],
22	]	SYM	O	]	dep	14	SENT_42	[p4l882t447r1153b545],
23	-	:	O	-	_	0	SENT_42	[p4l882t447r1153b545],
24	(	NN	O	(	dep	11	SENT_42	[p4l882t447r1153b545],
25	1	CD	NUMBER	1	number	26	SENT_42	[p4l882t447r1153b545],
26	—	CD	NUMBER	—	rcmod	24	SENT_42	[p4l1184t500r1226b503],
27	E	NN	O	e	dep	26	SENT_42	[p4l1247t455r1627b546],
28	]	SYM	O	]	dep	26	SENT_42	[p4l1247t455r1627b546],
29	-	:	O	-	_	0	SENT_42	[p4l1247t455r1627b546],
30	/	:	O	/	punct	33	SENT_42	[p4l1247t455r1627b546],
31	nj	SYM	O	nj	dep	33	SENT_42	[p4l1247t455r1627b546],
32	-	:	O	-	_	0	SENT_42	[p4l1247t455r1627b546],
33	)	NN	O	)	dep	9	SENT_42	[p4l1247t455r1627b546],
34	~	NN	O	~	nn	35	SENT_42	[p4l1247t455r1627b546],
35	X	NN	O	x	dep	9	SENT_42	[p4l1247t455r1627b546],
36	§	CD	NUMBER	§	num	37	SENT_42	[p4l1247t455r1627b546],
37	]	NN	O	]	dep	35	SENT_42	[p4l1247t455r1627b546],
38	,	,	O	,	_	0	SENT_42	[p4l1247t455r1627b546],
39	where	WRB	O	where	advmod	59	SENT_42	[p4l1651t465r1854b519],
40	nj	NN	O	nj	nsubj	59	SENT_42	[p4l1880t481r1950b544],
41	,	,	O	,	_	0	SENT_42	[p4l1880t481r1950b544],
42	number	NN	O	number	appos	40	SENT_42	[p4l1977t481r2151b519, p4l17t571r122b625],
43	of	IN	O	of	_	0	SENT_42	[p4l146t571r212b625],
44	observations	NNS	O	observation	prep_of	42	SENT_42	[p4l229t571r638b625],
45	in	IN	O	in	_	0	SENT_42	[p4l665t572r723b625],
46	the	DT	O	the	det	48	SENT_42	[p4l748t571r849b625],
47	jth	NN	O	jth	nn	48	SENT_42	[p4l863t571r960b639],
48	group	NN	O	group	prep_in	44	SENT_42	[p4l984t587r1191b639],
49	;	:	O	;	_	0	SENT_42	[p4l984t587r1191b639],
50	Oj	NN	O	oj	dep	48	SENT_42	[p4l1223t574r1282b650],
51	=	JJ	O	=	amod	52	SENT_42	[p4l1301t594r1334b610],
52	Z213	NN	O	z213	dep	50	SENT_42	[p4l1352t565r1557b650],
53	/	:	O	/	punct	50	SENT_42	[p4l1352t565r1557b650],
54	,	,	O	,	_	0	SENT_42	[p4l1352t565r1557b650],
55	-	:	O	-	_	0	SENT_42	[p4l1352t565r1557b650],
56	J	NN	O	j	dep	48	SENT_42	[p4l1352t565r1557b650],
57	-	:	O	-	_	0	SENT_42	[p4l1352t565r1557b650],
58	,	,	O	,	_	0	SENT_42	[p4l1352t565r1557b650],
59	observed	VBN	O	observe	rcmod	35	SENT_42	[p4l1583t571r1873b625],
60	number	NN	O	number	dobj	59	SENT_42	[p4l1900t571r2153b625],
61	of	IN	O	of	_	0	SENT_42	[p4l18t660r84b714],
62	cases	NNS	O	case	prep_of	60	SENT_42	[p4l99t676r263b714],
63	in	IN	O	in	_	0	SENT_42	[p4l287t661r346b714],
64	the	DT	O	the	det	66	SENT_42	[p4l368t660r469b714],
65	jth	NN	O	jth	nn	66	SENT_42	[p4l480t660r577b728],
66	group	NN	O	group	prep_in	62	SENT_42	[p4l598t676r801b728],
67	,	,	O	,	_	0	SENT_42	[p4l598t676r801b728],
68	E	NN	O	e	appos	66	SENT_42	[p4l822t663r893b738],
69	]	SYM	O	]	dep	60	SENT_42	[p4l822t663r893b738],
70	-	:	O	-	_	0	SENT_42	[p4l822t663r893b738],
71	,	,	O	,	_	0	SENT_42	[p4l822t663r893b738],
72	j	NN	O	j	appos	35	SENT_42	[p4l918t653r1090b739],
73	*	CD	NUMBER	*	dep	35	SENT_42	[p4l918t653r1090b739],
74	expected	VBN	O	expect	partmod	73	SENT_42	[p4l1113t660r1402b728],
75	number	NN	O	number	dobj	74	SENT_42	[p4l1426t660r1680b714],
76	of	IN	O	of	_	0	SENT_42	[p4l1700t660r1766b714],
77	cases	NNS	O	case	prep_of	8	SENT_42	[p4l1781t676r1945b714],
78	in	IN	O	in	_	0	SENT_42	[p4l1969t661r2028b714],
79	the	DT	O	the	det	81	SENT_42	[p4l2050t660r2151b714],
80	jth	NN	O	jth	nn	81	SENT_42	[p4l6t748r103b816],
81	group	NN	O	group	prep_in	8	SENT_42	[p4l124t764r327b816],
82	.	.	O	.	_	0	SENT_42	[p4l124t764r327b816],

1	The	DT	O	the	det	3	SENT_43	[p4l117t836r233b890],
2	interaction	NN	O	interaction	nn	3	SENT_43	[p4l259t836r610b890],
3	analysis	NN	O	analysis	nsubj	4	SENT_43	[p4l634t836r887b903],
4	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_43	[p4l914t835r1241b890],
5	the	DT	O	the	det	6	SENT_43	[p4l1266t836r1367b890],
6	above	JJ	O	above	dobj	4	SENT_43	[p4l1392t835r1579b890],
7	described	VBN	O	describe	partmod	6	SENT_43	[p4l1604t836r1913b890],
8	results	NNS	O	result	dobj	7	SENT_43	[p4l1938t836r2150b890],
9	for	IN	O	for	_	0	SENT_43	[p4l18t923r108b977],
10	rosuvastatin	NN	O	rosuvastatin	prep_for	8	SENT_43	[p4l129t924r526b977],
11	(	CD	NUMBER	(	num	10	SENT_43	[p4l549t923r720b990],
12	each	DT	O	each	det	14	SENT_43	[p4l549t923r720b990],
13	p	NN	O	p	dep	14	SENT_43	[p4l738t938r777b990],
14	<	JJR	O	<	dep	22	SENT_43	[p4l793t935r825b970],
15	0.0002	CD	NUMBER	0.0002	num	16	SENT_43	[p4l843t923r1084b990],
16	)	NN	O	)	dep	14	SENT_43	[p4l843t923r1084b990],
17	and	CC	O	and	_	0	SENT_43	[p4l1107t923r1223b977],
18	atorvastatin	NN	O	atorvastatin	conj_and	16	SENT_43	[p4l1247t924r1633b977],
19	(	CD	NUMBER	(	num	18	SENT_43	[p4l1656t923r1828b990],
20	each	DT	O	each	det	21	SENT_43	[p4l1656t923r1828b990],
21	p	NN	O	p	dep	22	SENT_43	[p4l1846t939r1884b990],
22	<	JJR	O	<	dep	8	SENT_43	[p4l1901t935r1933b970],
23	0.001	CD	NUMBER	0.001	num	24	SENT_43	[p4l1951t923r2151b990],
24	)	NN	O	)	dep	22	SENT_43	[p4l1951t923r2151b990],
25	in	IN	O	in	_	0	SENT_43	[p4l18t1011r78b1063],
26	combination	NN	O	combination	prep_in	8	SENT_43	[p4l106t1010r511b1064],
27	with	IN	O	with	_	0	SENT_43	[p4l538t1010r686b1064],
28	different	JJ	O	different	amod	29	SENT_43	[p4l714t1010r992b1064],
29	polymorphisms	NNS	O	polymorphism	prep_with	7	SENT_43	[p4l1020t1010r1540b1077],
30	.	.	O	.	_	0	SENT_43	[p4l1020t1010r1540b1077],

1	Furthermore	RB	O	furthermore	advmod	3	SENT_44	[p4l1570t1010r1978b1064],
2	both	DT	O	both	nsubj	3	SENT_44	[p4l2006t1010r2152b1064],
3	resampling	VBG	O	resample	_	0	SENT_44	[p4l18t1097r379b1165],
4	technique	NN	O	technique	dobj	3	SENT_44	[p4l397t1097r717b1165],
5	(	CD	NUMBER	(	num	4	SENT_44	[p4l737t1097r909b1164],
6	each	DT	O	each	dep	4	SENT_44	[p4l737t1097r909b1164],
7	obtained	VBN	O	obtain	partmod	4	SENT_44	[p4l929t1097r1210b1151],
8	two-sided	JJ	O	two-sided	amod	9	SENT_44	[p4l1230t1097r1554b1151],
9	p	NN	O	p	nsubj	23	SENT_44	[p4l1570t1113r1609b1165],
10	<	JJR	O	<	dep	23	SENT_44	[p4l1625t1109r1658b1144],
11	0.001	CD	NUMBER	0.001	num	12	SENT_44	[p4l1675t1097r1876b1164],
12	)	NN	O	)	dep	18	SENT_44	[p4l1675t1097r1876b1164],
13	and	CC	O	and	_	0	SENT_44	[p4l1896t1097r2012b1151],
14	discrimination	NN	O	discrimination	conj_and	12	SENT_44	[p4l2033t1097r2150b1151, p4l18t1185r393b1238],
15	analysis	NN	O	analysis	dep	18	SENT_44	[p4l426t1184r680b1252],
16	(	CD	NUMBER	(	num	15	SENT_44	[p4l715t1184r886b1252],
17	each	DT	O	each	det	18	SENT_44	[p4l715t1184r886b1252],
18	p	NN	O	p	dep	23	SENT_44	[p4l915t1184r1220b1252],
19	<	JJR	O	<	dep	18	SENT_44	[p4l915t1184r1220b1252],
20	0.001	CD	NUMBER	0.001	num	21	SENT_44	[p4l915t1184r1220b1252],
21	)	NN	O	)	nsubj	23	SENT_44	[p4l915t1184r1220b1252],
22	were	VBD	O	be	cop	23	SENT_44	[p4l1252t1200r1412b1238],
23	conﬁrmatory	JJ	O	conﬁrmatory	xcomp	7	SENT_44	[p4l1447t1184r1868b1252],
24	and	CC	O	and	_	0	SENT_44	[p4l1900t1184r2016b1238],
25	the	DT	O	the	det	27	SENT_44	[p4l2050t1184r2151b1238],
26	rs4693075	NN	O	rs4693075	nn	27	SENT_44	[p4l19t1274r356b1326],
27	variant	NN	O	variant	nsubjpass	33	SENT_44	[p4l384t1272r613b1325],
28	within	IN	O	within	_	0	SENT_44	[p4l638t1271r849b1325],
29	the	DT	O	the	det	31	SENT_44	[p4l876t1271r977b1326],
30	COQ2	NN	O	coq2	nn	31	SENT_44	[p4l1006t1274r1176b1336],
31	gene	NN	O	gene	prep_within	27	SENT_44	[p4l1202t1287r1353b1339],
32	was	VBD	O	be	auxpass	33	SENT_44	[p4l1380t1287r1504b1326],
33	associated	VBN	O	associate	conj_and	3	SENT_44	[p4l1533t1271r1863b1326],
34	for	IN	O	for	_	0	SENT_44	[p4l1892t1271r1981b1325],
35	both	DT	O	both	det	36	SENT_44	[p4l2006t1271r2152b1326],
36	statins	NNS	O	statin	prep_for	33	SENT_44	[p4l19t1359r228b1413],
37	with	IN	O	with	_	0	SENT_44	[p4l260t1359r408b1413],
38	complete	JJ	O	complete	prep_with	33	SENT_44	[p4l440t1359r737b1426],
39	deﬁned	VBN	O	deﬁned	partmod	38	SENT_44	[p4l770t1358r1009b1413],
40	myopathy	NN	O	myopathy	dobj	39	SENT_44	[p4l1042t1359r1369b1426],
41	(	CD	NUMBER	(	num	40	SENT_44	[p4l1400t1358r1571b1426],
42	both	CC	O	both	dep	40	SENT_44	[p4l1400t1358r1571b1426],
43	myalgias	NNS	O	myalgia	dobj	39	SENT_44	[p4l1603t1359r1886b1426],
44	and	CC	O	and	_	0	SENT_44	[p4l1919t1359r2035b1413],
45	CK	NN	O	ck	nn	46	SENT_44	[p4l2068t1361r2153b1413],
46	increase	NN	O	increase	dobj	39	SENT_44	[p4l18t1446r307b1513],
47	)	CD	NUMBER	)	number	48	SENT_44	[p4l18t1446r307b1513],
48	(	CD	NUMBER	(	dep	51	SENT_44	[p4l330t1446r502b1513],
49	each	DT	O	each	det	50	SENT_44	[p4l330t1446r502b1513],
50	p	NN	O	p	npadvmod	51	SENT_44	[p4l519t1462r557b1513],
51	<	JJR	O	<	amod	46	SENT_44	[p4l574t1458r607b1492],
52	0.0003	CD	NUMBER	0.0003	num	53	SENT_44	[p4l624t1446r881b1513],
53	)	NN	O	)	dep	46	SENT_44	[p4l624t1446r881b1513],
54	.	.	O	.	_	0	SENT_44	[p4l624t1446r881b1513],

1	Such	JJ	O	such	amod	3	SENT_45	[p4l120t1533r271b1587],
2	preliminary	JJ	O	preliminary	amod	3	SENT_45	[p4l298t1533r678b1601],
3	data	NNS	O	datum	nsubj	23	SENT_45	[p4l703t1533r840b1587],
4	in	IN	O	in	_	0	SENT_45	[p4l867t1534r926b1587],
5	the	DT	O	the	det	7	SENT_45	[p4l951t1533r1053b1587],
6	speciﬁc	NN	O	speciﬁc	nn	7	SENT_45	[p4l1081t1533r1319b1601],
7	setting	NN	O	setting	prep_in	3	SENT_45	[p4l1346t1534r1565b1601],
8	of	IN	O	of	_	0	SENT_45	[p4l1591t1533r1657b1587],
9	genetic	JJ	O	genetic	amod	10	SENT_45	[p4l1675t1534r1908b1601],
10	model	NN	O	model	prep_of	7	SENT_45	[p4l1935t1533r2150b1595],
11	,	,	O	,	_	0	SENT_45	[p4l1935t1533r2150b1595],
12	the	DT	O	the	det	13	SENT_45	[p4l17t1620r119b1674],
13	best	JJS	O	best	dobj	19	SENT_45	[p4l138t1620r271b1674],
14	of	IN	O	of	_	0	SENT_45	[p4l289t1620r355b1674],
15	our	PRP$	O	we	poss	16	SENT_45	[p4l367t1636r476b1674],
16	knowledge	NN	O	knowledge	prep_of	13	SENT_45	[p4l494t1620r846b1688],
17	the	DT	O	the	det	18	SENT_45	[p4l865t1620r966b1674],
18	ﬁrst	NN	O	ﬁrst	nsubj	19	SENT_45	[p4l987t1620r1114b1674],
19	described	VBN	O	describe	rcmod	3	SENT_45	[p4l1132t1620r1440b1674],
20	for	IN	O	for	_	0	SENT_45	[p4l1461t1620r1550b1674],
21	rosuvastatin	NN	O	rosuvastatin	prep_for	19	SENT_45	[p4l1568t1621r1980b1682],
22	,	,	O	,	_	0	SENT_45	[p4l1568t1621r1980b1682],
23	indicate	VBP	O	indicate	_	0	SENT_45	[p4l2001t1620r2151b1674, p4l18t1715r146b1761],
24	that	IN	O	that	complm	38	SENT_45	[p4l175t1707r304b1761],
25	some	DT	O	some	det	27	SENT_45	[p4l332t1723r500b1761],
26	different	JJ	O	different	amod	27	SENT_45	[p4l529t1707r807b1761],
27	pathways	NNS	O	pathway	nsubj	38	SENT_45	[p4l835t1707r1143b1775],
28	other	JJ	O	other	amod	27	SENT_45	[p4l1173t1707r1345b1761],
29	than	IN	O	than	_	0	SENT_45	[p4l1371t1707r1516b1761],
30	factors	NNS	O	factor	prep_than	27	SENT_45	[p4l1545t1707r1758b1761],
31	involved	VBN	O	involve	partmod	30	SENT_45	[p4l1789t1707r2063b1761],
32	in	IN	O	in	_	0	SENT_45	[p4l2093t1708r2152b1761],
33	the	DT	O	the	det	34	SENT_45	[p4l17t1794r119b1849],
34	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	31	SENT_45	[p4l137t1794r710b1862],
35	of	IN	O	of	_	0	SENT_45	[p4l729t1794r795b1848],
36	statins	NNS	O	statin	prep_of	34	SENT_45	[p4l806t1795r1015b1849],
37	could	MD	O	could	aux	38	SENT_45	[p4l1034t1794r1208b1849],
38	inﬂuence	VB	O	inﬂuence	ccomp	23	SENT_45	[p4l1227t1794r1521b1849],
39	the	DT	O	the	det	40	SENT_45	[p4l1539t1794r1640b1849],
40	onset	NN	O	onset	dobj	38	SENT_45	[p4l1658t1802r1832b1849],
41	of	IN	O	of	_	0	SENT_45	[p4l1849t1794r1915b1849],
42	muscle	NN	O	muscle	nn	44	SENT_45	[p4l1926t1794r2151b1849],
43	side	NN	O	side	nn	44	SENT_45	[p4l19t1881r144b1936],
44	effects	NNS	O	effect	prep_of	40	SENT_45	[p4l164t1881r387b1936],
45	.	.	O	.	_	0	SENT_45	[p4l164t1881r387b1936],

1	Indeed	RB	O	indeed	dep	4	SENT_46	[p4l407t1882r623b1936],
2	our	PRP$	O	we	poss	4	SENT_46	[p4l643t1897r752b1936],
3	data	NNS	O	datum	nn	4	SENT_46	[p4l768t1882r905b1936],
4	ﬁt	NN	O	ﬁt	_	0	SENT_46	[p4l924t1881r990b1936],
5	with	IN	O	with	_	0	SENT_46	[p4l1006t1882r1154b1936],
6	the	DT	O	the	det	8	SENT_46	[p4l1171t1882r1273b1936],
7	previous	JJ	O	previous	amod	8	SENT_46	[p4l1292t1882r1567b1949],
8	evidence	NN	O	evidence	prep_with	4	SENT_46	[p4l1587t1882r1870b1936],
9	by	IN	O	by	_	0	SENT_46	[p4l1889t1881r1966b1949],
10	Pasanen	NNP	PERSON	Pasanen	prep_by	8	SENT_46	[p4l1984t1885r2151b1936, p4l18t1984r136b2023],
11	and	CC	O	and	_	0	SENT_46	[p4l156t1969r271b2023],
12	co-workers	NNS	O	co-worker	conj_and	10	SENT_46	[p4l292t1969r655b2023],
13	that	WDT	O	that	dobj	15	SENT_46	[p4l675t1969r804b2023],
14	atorvastatin	NN	O	atorvastatin	nsubj	15	SENT_46	[p4l822t1970r1209b2023],
15	had	VBD	O	have	rcmod	4	SENT_46	[p4l1229t1969r1344b2023],
16	greater	JJR	O	greater	amod	18	SENT_46	[p4l1363t1977r1595b2036],
17	mean	JJ	O	mean	amod	18	SENT_46	[p4l1613t1984r1790b2023],
18	area	NN	O	area	dobj	15	SENT_46	[p4l1809t1984r1944b2023],
19	under	IN	O	under	_	0	SENT_46	[p4l1963t1969r2153b2023],
20	the	DT	O	the	det	25	SENT_46	[p4l17t2056r119b2110],
21	plasma	NN	O	plasma	nn	25	SENT_46	[p4l142t2056r370b2124],
22	concentration	NN	O	concentration	nn	25	SENT_46	[p4l392t2057r1029b2110],
23	—	CD	NUMBER	—	num	25	SENT_46	[p4l392t2057r1029b2110],
24	time	NN	O	time	nn	25	SENT_46	[p4l392t2057r1029b2110],
25	curve	NN	O	curve	prep_under	18	SENT_46	[p4l1051t2072r1226b2110],
26	with	IN	O	with	_	0	SENT_46	[p4l1247t2056r1395b2110],
27	respect	NN	O	respect	prep_with	25	SENT_46	[p4l1417t2064r1650b2124],
28	to	TO	O	to	_	0	SENT_46	[p4l1670t2064r1732b2110],
29	rosuvastatin	NN	O	rosuvastatin	prep_to	15	SENT_46	[p4l1755t2057r2152b2110],
30	according	VBG	O	accord	_	0	SENT_46	[p4l18t2143r332b2211],
31	to	TO	O	to	prepc_according_to	15	SENT_46	[p4l352t2151r413b2197],
32	speciﬁc	VB	O	speciﬁc	pcomp	15	SENT_46	[p4l437t2143r675b2211],
33	SLC01B1	NN	O	slc01b1	nn	34	SENT_46	[p4l694t2146r960b2197],
34	variants	NNS	O	variant	nsubj	37	SENT_46	[p4l988t2144r1245b2197],
35	[	CD	NUMBER	[	number	36	SENT_46	[p4l1272t2143r1371b2211],
36	9	CD	NUMBER	9	num	37	SENT_46	[p4l1272t2143r1371b2211],
37	]	NN	O	]	xcomp	32	SENT_46	[p4l1272t2143r1371b2211],
38	.	.	O	.	_	0	SENT_46	[p4l1272t2143r1371b2211],

1	In	IN	O	in	_	0	SENT_47	[p4l120t2234r180b2284],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_47	[p4l211t2230r570b2293],
3	,	,	O	,	_	0	SENT_47	[p4l211t2230r570b2293],
4	our	PRP$	O	we	poss	5	SENT_47	[p4l602t2246r711b2285],
5	opinion	NN	O	opinion	nsubj	6	SENT_47	[p4l740t2231r985b2298],
6	is	VBZ	O	be	_	0	SENT_47	[p4l1017t2231r1063b2285],
7	that	IN	O	that	complm	12	SENT_47	[p4l1094t2230r1223b2285],
8	further	JJ	O	further	amod	10	SENT_47	[p4l1254t2230r1480b2285],
9	genome-wide	JJ	O	genome-wide	amod	10	SENT_47	[p4l1508t2230r1953b2298],
10	studies	NNS	O	study	nsubjpass	12	SENT_47	[p4l1986t2230r2151b2285, p4l19t2318r102b2372],
11	are	VBP	O	be	auxpass	12	SENT_47	[p4l141t2333r239b2371],
12	warranted	VBN	O	warrant	ccomp	6	SENT_47	[p4l275t2317r611b2372],
13	to	TO	O	to	aux	15	SENT_47	[p4l650t2325r711b2371],
14	better	JJR	O	better	advmod	15	SENT_47	[p4l749t2317r944b2372],
15	personalize	VB	O	personalize	xcomp	12	SENT_47	[p4l980t2317r1348b2385],
16	single	JJ	O	single	amod	18	SENT_47	[p4l1388t2317r1573b2385],
17	statin	NN	O	statin	nn	18	SENT_47	[p4l1613t2318r1792b2372],
18	treatment	NN	O	treatment	dobj	15	SENT_47	[p4l1829t2325r2153b2372],
19	according	VBG	O	accord	_	0	SENT_47	[p4l18t2405r332b2472],
20	to	TO	O	to	prepc_according_to	15	SENT_47	[p4l355t2413r416b2459],
21	speciﬁc	JJ	O	speciﬁc	amod	23	SENT_47	[p4l444t2404r682b2472],
22	pharmacological	JJ	O	pharmacological	amod	23	SENT_47	[p4l707t2405r1239b2472],
23	differences	NNS	O	difference	pobj	15	SENT_47	[p4l1265t2404r1617b2459],
24	(	VBP	O	(	rcmod	23	SENT_47	[p4l1644t2405r1755b2472],
25	i.e.	FW	O	i.e.	nsubj	27	SENT_47	[p4l1644t2405r1755b2472],
26	hydrophilic	JJ	O	hydrophilic	amod	27	SENT_47	[p4l1783t2404r2152b2472],
27	properties	NNS	O	property	ccomp	24	SENT_47	[p4l18t2493r347b2559],
28	and/or	JJ	O	and/or	amod	30	SENT_47	[p4l369t2492r581b2559],
29	metabolic	JJ	O	metabolic	amod	30	SENT_47	[p4l601t2492r918b2546],
30	pathways	NNS	O	pathway	dobj	27	SENT_47	[p4l939t2492r1247b2559],
31	both	CC	O	both	dep	30	SENT_47	[p4l1269t2492r1415b2546],
32	hepatic	JJ	O	hepatic	amod	35	SENT_47	[p4l1436t2492r1671b2559],
33	and	CC	O	and	_	0	SENT_47	[p4l1691t2492r1807b2546],
34	muscular	JJ	O	muscular	conj_and	32	SENT_47	[p4l1829t2492r2151b2559],
35	)	NN	O	)	conj	30	SENT_47	[p4l1829t2492r2151b2559],
36	among	IN	O	among	_	0	SENT_47	[p4l18t2595r237b2647],
37	molecules	NNS	O	molecule	prep_among	35	SENT_47	[p4l255t2579r577b2633],
38	of	IN	O	of	_	0	SENT_47	[p4l597t2579r664b2633],
39	the	DT	O	the	det	40	SENT_47	[p4l674t2579r775b2633],
40	class	NN	O	class	prep_of	37	SENT_47	[p4l794t2579r942b2633],
41	both	CC	O	both	preconj	42	SENT_47	[p4l961t2579r1107b2633],
42	in	IN	O	in	prep	27	SENT_47	[p4l1126t2580r1184b2633],
43	solely	RB	O	solely	pcomp	42	SENT_47	[p4l1203t2579r1389b2647],
44	and	CC	O	and	_	0	SENT_47	[p4l1405t2579r1521b2633],
45	in	IN	O	in	prep	27	SENT_47	[p4l1541t2580r1600b2633],
46	association	NN	O	association	nn	47	SENT_47	[p4l1618t2580r1974b2633],
47	therapy	NN	O	therapy	pobj	45	SENT_47	[p4l1992t2579r2151b2633, p4l18t2682r133b2734],
48	as	IN	O	as	mark	50	SENT_47	[p4l147t2682r208b2720],
49	frequently	RB	O	frequently	advmod	50	SENT_47	[p4l226t2666r561b2734],
50	occurs	VBZ	O	occur	advcl	24	SENT_47	[p4l576t2682r780b2720],
51	in	IN	O	in	_	0	SENT_47	[p4l797t2667r856b2720],
52	the	DT	O	the	det	54	SENT_47	[p4l872t2666r973b2720],
53	clinical	JJ	O	clinical	amod	54	SENT_47	[p4l989t2666r1215b2720],
54	practice	NN	O	practice	prep_in	50	SENT_47	[p4l1232t2667r1486b2734],
55	of	IN	O	of	_	0	SENT_47	[p4l1502t2666r1569b2720],
56	atherothrombosis	NN	O	atherothrombosis	nn	57	SENT_47	[p4l1577t2666r2150b2720],
57	prevention	NN	O	prevention	prep_of	54	SENT_47	[p4l18t2754r369b2821],
58	and	CC	O	and	_	0	SENT_47	[p4l391t2753r507b2807],
59	treatment	NN	O	treatment	prep_of	54	SENT_47	[p4l530t2761r867b2808],
60	.	.	O	.	_	0	SENT_47	[p4l530t2761r867b2808],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_48	[p4l17t2935r279b2989],
2	of	IN	O	of	_	0	SENT_48	[p4l298t2935r370b2989],
3	interest	NN	O	interest	prep_of	1	SENT_48	[p4l385t2935r649b2989],

1	There	EX	O	there	expl	2	SENT_49	[p4l117t3112r299b3166],
2	is	VBZ	O	be	_	0	SENT_49	[p4l317t3113r363b3166],
3	no	DT	O	no	det	4	SENT_49	[p4l381t3128r458b3166],
4	conﬂict	NN	O	conﬂict	nsubj	2	SENT_49	[p4l475t3112r712b3166],
5	of	IN	O	of	_	0	SENT_49	[p4l728t3112r794b3166],
6	interest	NN	O	interest	prep_of	4	SENT_49	[p4l803t3113r1050b3166],
7	for	IN	O	for	_	0	SENT_49	[p4l1065t3112r1155b3166],
8	each	DT	O	each	det	9	SENT_49	[p4l1169t3112r1314b3166],
9	author	NN	O	author	prep_for	6	SENT_49	[p4l1330t3112r1544b3166],
10	in	IN	O	in	_	0	SENT_49	[p4l1559t3113r1618b3166],
11	connection	NN	O	connection	prep_in	9	SENT_49	[p4l1634t3113r1990b3166],
12	with	IN	O	with	_	0	SENT_49	[p4l2004t3112r2152b3166],
13	the	DT	O	the	det	15	SENT_49	[p4l17t3199r119b3254],
14	present	JJ	DATE	present	amod	15	SENT_49	[p4l142t3207r384b3267],
15	correspondence	NN	O	correspondence	prep_with	11	SENT_49	[p4l405t3199r932b3267],
16	.	.	O	.	_	0	SENT_49	[p4l405t3199r932b3267],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_50	[p4l7t3300r650b3368],

1	The	DT	O	the	det	3	SENT_51	[p4l110t3478r227b3533],
2	ongoing	JJ	O	ongoing	amod	3	SENT_51	[p4l259t3479r519b3547],
3	study	NN	O	study	nsubjpass	6	SENT_51	[p4l550t3478r727b3547],
4	is	VBZ	O	be	auxpass	6	SENT_51	[p4l757t3479r803b3533],
5	partially	RB	O	partially	advmod	6	SENT_51	[p4l837t3478r1106b3547],
6	supported	VBN	O	support	_	0	SENT_51	[p4l1137t3478r1464b3547],
7	by	IN	O	by	_	0	SENT_51	[p4l1495t3478r1572b3547],
8	a	DT	O	a	det	9	SENT_51	[p4l1602t3494r1634b3533],
9	grant	NN	O	grant	agent	6	SENT_51	[p4l1664t3486r1835b3547],
10	from	IN	O	from	_	0	SENT_51	[p4l1865t3478r2018b3533],
11	the	DT	O	the	prep_from	9	SENT_51	[p4l2049t3478r2151b3533],

1	University	NNP	ORGANIZATION	University	_	0	SENT_52	[p4l10t3568r345b3636],
2	of	IN	ORGANIZATION	of	_	0	SENT_52	[p4l365t3567r432b3622],
3	Siena	NNP	ORGANIZATION	Siena	prep_of	1	SENT_52	[p4l447t3568r632b3623],
4	.	.	O	.	_	0	SENT_52	[p4l447t3568r632b3623],

1	References	NNS	O	reference	_	0	SENT_53	[p4l10t3749r379b3804],

1	[	NN	O	[	_	0	SENT_54	[p5l7t104r47b158],
2	1	CD	NUMBER	1	num	1	SENT_54	[p5l7t104r47b158],
3	]	CD	NUMBER	]	num	5	SENT_54	[p5l61t104r72b158],
4	Baigent	NN	O	baigent	nn	5	SENT_54	[p5l107t105r300b158],
5	C	NN	O	c	dep	1	SENT_54	[p5l313t106r355b154],
6	,	,	O	,	_	0	SENT_54	[p5l313t106r355b154],
7	Keech	NNP	PERSON	Keech	nn	8	SENT_54	[p5l371t104r524b147],
8	A	NNP	O	A	appos	5	SENT_54	[p5l536t106r584b154],
9	,	,	O	,	_	0	SENT_54	[p5l536t106r584b154],
10	Kearney	NNP	PERSON	Kearney	nn	11	SENT_54	[p5l599t106r810b158],
11	PM	NNP	O	PM	appos	5	SENT_54	[p5l823t107r916b154],
12	,	,	O	,	_	0	SENT_54	[p5l823t107r916b154],
13	et	FW	O	et	nn	14	SENT_54	[p5l931t110r979b147],
14	al.	FW	O	al.	appos	5	SENT_54	[p5l992t104r1047b148],
15	.	.	O	.	_	0	SENT_54	[p5l992t104r1047b148],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_55	[p5l1062t104r1260b158],
2	and	CC	O	and	_	0	SENT_55	[p5l1273t104r1366b147],
3	Safety	NN	O	safety	conj_and	1	SENT_55	[p5l1380t104r1538b158],
4	of	IN	O	of	_	0	SENT_55	[p5l1550t104r1604b147],
5	cho1estero1	NN	O	cho1estero1	nn	8	SENT_55	[p5l1611t104r2153b158],
6	—	CD	NUMBER	—	num	8	SENT_55	[p5l1611t104r2153b158],
7	lowering	NN	O	lowering	nn	8	SENT_55	[p5l1611t104r2153b158],
8	treatment	NN	O	treatment	prep_of	1	SENT_55	[p5l106t177r380b214],
9	:	:	O	:	_	0	SENT_55	[p5l106t177r380b214],
10	prospective	JJ	O	prospective	amod	11	SENT_55	[p5l411t171r710b225],
11	meta-analysis	NN	O	meta-analysis	dep	1	SENT_55	[p5l737t170r1096b225],
12	of	IN	O	of	_	0	SENT_55	[p5l1123t170r1177b214],
13	data	NNS	O	datum	prep_of	11	SENT_55	[p5l1197t170r1307b214],
14	from	IN	O	from	_	0	SENT_55	[p5l1333t170r1456b214],
15	90,056	CD	NUMBER	90,056	num	16	SENT_55	[p5l1482t172r1655b220],
16	participants	NNS	O	participant	prep_from	13	SENT_55	[p5l1681t171r1989b225],
17	in	IN	O	in	_	0	SENT_55	[p5l2017t171r2064b213],
18	14	CD	NUMBER	14	num	20	SENT_55	[p5l2093t172r2152b213],
19	randomised	JJ	O	randomised	amod	20	SENT_55	[p5l107t236r412b279],
20	trials	NNS	O	trial	prep_in	16	SENT_55	[p5l430t236r559b279],
21	of	IN	O	of	_	0	SENT_55	[p5l578t235r631b279],
22	statins	NNS	O	statin	prep_of	20	SENT_55	[p5l643t236r825b280],
23	.	.	O	.	_	0	SENT_55	[p5l643t236r825b280],

1	Lancet	NNP	O	Lancet	_	0	SENT_56	[p5l844t238r1010b279],
2	2005	CD	DATE	2005	num	1	SENT_56	[p5l1027t238r1501b286],
3	;	:	O	;	_	0	SENT_56	[p5l1027t238r1501b286],
4	366:1267	CD	NUMBER	366:1267	number	5	SENT_56	[p5l1027t238r1501b286],
5	—	CD	NUMBER	—	dep	1	SENT_56	[p5l1027t238r1501b286],
6	8	CD	NUMBER	8	dep	5	SENT_56	[p5l1027t238r1501b286],
7	.	.	O	.	_	0	SENT_56	[p5l1027t238r1501b286],

1	[	NN	O	[	nn	5	SENT_57	[p5l7t302r72b356],
2	2	CD	NUMBER	2	num	5	SENT_57	[p5l7t302r72b356],
3	]	CD	NUMBER	]	num	5	SENT_57	[p5l7t302r72b356],
4	Ho	NNP	O	Ho	nn	5	SENT_57	[p5l106t305r176b346],
5	PM	NNP	O	PM	_	0	SENT_57	[p5l189t305r282b352],
6	,	,	O	,	_	0	SENT_57	[p5l189t305r282b352],
7	Magid	NNP	PERSON	Magid	nn	8	SENT_57	[p5l296t302r454b356],
8	Dj	NNP	PERSON	Dj	appos	5	SENT_57	[p5l467t303r533b356],
9	,	,	O	,	_	0	SENT_57	[p5l467t303r533b356],
10	Shetterly	NNP	PERSON	Shetterly	nn	11	SENT_57	[p5l547t302r781b356],
11	SM	NNP	O	SM	appos	5	SENT_57	[p5l792t304r883b352],
12	,	,	O	,	_	0	SENT_57	[p5l792t304r883b352],
13	et	FW	O	et	nn	14	SENT_57	[p5l896t308r944b346],
14	al.	FW	O	al.	appos	5	SENT_57	[p5l955t302r1010b346],
15	.	.	O	.	_	0	SENT_57	[p5l955t302r1010b346],

1	Medication	NN	O	medication	nn	2	SENT_58	[p5l1023t302r1314b346],
2	nonadherence	NN	O	nonadherence	nsubjpass	4	SENT_58	[p5l1326t302r1693b346],
3	is	VBZ	O	be	auxpass	4	SENT_58	[p5l1706t303r1743b346],
4	associated	VBN	O	associate	_	0	SENT_58	[p5l1756t302r2022b346],
5	with	IN	O	with	_	0	SENT_58	[p5l2033t302r2152b346],
6	a	DT	O	a	det	8	SENT_58	[p5l106t380r132b411],
7	broad	JJ	O	broad	amod	8	SENT_58	[p5l149t367r296b411],
8	range	NN	O	range	prep_with	4	SENT_58	[p5l314t380r456b422],
9	of	IN	O	of	_	0	SENT_58	[p5l474t367r528b411],
10	diverse	JJ	O	diverse	amod	11	SENT_58	[p5l539t367r724b411],
11	outcomes	NNS	O	outcome	prep_of	8	SENT_58	[p5l741t374r990b411],
12	in	IN	O	in	_	0	SENT_58	[p5l1009t368r1056b411],
13	patients	NNS	O	patient	prep_in	4	SENT_58	[p5l1073t368r1280b422],
14	with	IN	O	with	_	0	SENT_58	[p5l1297t367r1415b411],
15	coronary	JJ	O	coronary	amod	17	SENT_58	[p5l1432t380r1662b422],
16	artery	NN	O	artery	nn	17	SENT_58	[p5l1678t374r1833b422],
17	disease	NN	O	disease	prep_with	13	SENT_58	[p5l1849t367r2048b411],
18	.	.	O	.	_	0	SENT_58	[p5l1849t367r2048b411],

1	Am	VBP	O	be	dep	2	SENT_59	[p5l2064t369r2152b411],
2	Heart	NNP	O	Heart	_	0	SENT_59	[p5l107t437r280b488],
3	]	CD	NUMBER	]	number	4	SENT_59	[p5l107t437r280b488],
4	2008	CD	DATE	2008	amod	2	SENT_59	[p5l298t436r440b484],
5	;	:	O	;	_	0	SENT_59	[p5l298t436r440b484],
6	1	CD	NUMBER	1	num	7	SENT_59	[p5l451t436r471b477],
7	55:772	CD	NUMBER	55:772	dep	4	SENT_59	[p5l482t436r739b478],
8	—	CD	NUMBER	—	num	9	SENT_59	[p5l482t436r739b478],
9	9	CD	NUMBER	9	dep	7	SENT_59	[p5l482t436r739b478],
10	.	.	O	.	_	0	SENT_59	[p5l482t436r739b478],

1	[	NN	O	[	nn	4	SENT_60	[p5l8t500r72b555],
2	3	CD	NUMBER	3	num	4	SENT_60	[p5l8t500r72b555],
3	]	NN	O	]	nn	4	SENT_60	[p5l8t500r72b555],
4	Link	NN	O	link	_	0	SENT_60	[p5l107t500r215b543],
5	E	NN	O	e	dep	4	SENT_60	[p5l226t503r266b550],
6	,	,	O	,	_	0	SENT_60	[p5l226t503r266b550],
7	Parish	NNP	O	Parish	nn	8	SENT_60	[p5l280t500r437b544],
8	S	NNP	O	S	appos	5	SENT_60	[p5l449t502r487b551],
9	,	,	O	,	_	0	SENT_60	[p5l449t502r487b551],
10	Armitage	NNP	PERSON	Armitage	nn	11	SENT_60	[p5l498t501r776b555],
11	]	NNP	O	]	appos	5	SENT_60	[p5l498t501r776b555],
12	,	,	O	,	_	0	SENT_60	[p5l498t501r776b555],
13	et	FW	O	et	nn	14	SENT_60	[p5l789t507r837b544],
14	al.	FW	O	al.	appos	5	SENT_60	[p5l848t500r903b544],
15	.	.	O	.	_	0	SENT_60	[p5l848t500r903b544],

1	SLCO1	NN	O	slco1	nn	3	SENT_61	[p5l917t502r1071b544],
2	B1	NN	O	b1	nn	3	SENT_61	[p5l1082t503r1138b543],
3	variants	NNS	O	variant	_	0	SENT_61	[p5l1156t501r1362b544],
4	and	CC	O	and	_	0	SENT_61	[p5l1375t500r1469b544],
5	statin-induced	JJ	O	statin-induced	amod	6	SENT_61	[p5l1482t500r1858b544],
6	myopathy	NN	O	myopathy	conj_and	3	SENT_61	[p5l1871t500r2147b555],
7	:	:	O	:	_	0	SENT_61	[p5l1871t500r2147b555],

1	a	DT	O	a	det	3	SENT_62	[p5l106t578r132b609],
2	genomewide	JJ	O	genomewide	amod	3	SENT_62	[p5l149t566r483b620],
3	study	NN	O	study	_	0	SENT_62	[p5l502t566r655b620],
4	.	.	O	.	_	0	SENT_62	[p5l502t566r655b620],

1	N	NN	O	n	nn	3	SENT_63	[p5l674t568r712b609],
2	Engl	NNP	O	Engl	nn	3	SENT_63	[p5l730t566r871b620],
3	]	NNP	O	]	nsubj	4	SENT_63	[p5l730t566r871b620],
4	Med	VBD	O	med	_	0	SENT_63	[p5l890t566r1002b609],
5	2008	CD	DATE	2008	dobj	4	SENT_63	[p5l1020t568r1494b616],
6	;	:	O	;	_	0	SENT_63	[p5l1020t568r1494b616],
7	359:789	CD	NUMBER	359:789	number	8	SENT_63	[p5l1020t568r1494b616],
8	—	CD	NUMBER	—	dep	5	SENT_63	[p5l1020t568r1494b616],
9	99	CD	NUMBER	99	dep	8	SENT_63	[p5l1020t568r1494b616],
10	.	.	O	.	_	0	SENT_63	[p5l1020t568r1494b616],

1	[	NN	O	[	_	0	SENT_64	[p5l8t632r72b687],
2	4	CD	NUMBER	4	number	3	SENT_64	[p5l8t632r72b687],
3	]	CD	NUMBER	]	num	8	SENT_64	[p5l8t632r72b687],
4	Voora	NN	O	voora	nn	8	SENT_64	[p5l104t635r257b676],
5	D	NN	O	d	nn	8	SENT_64	[p5l274t635r323b682],
6	,	,	O	,	_	0	SENT_64	[p5l274t635r323b682],
7	Svati	NNP	O	Svati	dep	8	SENT_64	[p5l341t633r465b676],
8	HS	NN	O	h	dep	1	SENT_64	[p5l483t634r563b682],
9	,	,	O	,	_	0	SENT_64	[p5l483t634r563b682],
10	Spasojevic	JJ	PERSON	spasojevic	appos	8	SENT_64	[p5l581t633r850b687],
11	I	PRP	O	I	dep	1	SENT_64	[p5l867t635r892b683],
12	,	,	O	,	_	0	SENT_64	[p5l867t635r892b683],
13	et	FW	O	et	nn	14	SENT_64	[p5l911t639r959b676],
14	al.	FW	O	al.	appos	11	SENT_64	[p5l975t632r1030b676],
15	.	.	O	.	_	0	SENT_64	[p5l975t632r1030b676],

1	The	DT	O	the	det	3	SENT_65	[p5l1046t632r1139b676],
2	SLCO1B1	NN	O	slco1b1	nn	3	SENT_65	[p5l1157t632r1440b676],
3	*	NN	O	*	_	0	SENT_65	[p5l1157t632r1440b676],
4	5	CD	NUMBER	5	advmod	7	SENT_65	[p5l1157t632r1440b676],
5	genetic	JJ	O	genetic	amod	6	SENT_65	[p5l1458t633r1646b687],
6	variants	NNS	O	variant	dep	4	SENT_65	[p5l1661t633r1868b676],
7	associated	VBN	O	associate	dep	3	SENT_65	[p5l1886t632r2151b676],
8	with	IN	O	with	_	0	SENT_65	[p5l105t698r224b741],
9	statin-induced	JJ	O	statin-induced	amod	11	SENT_65	[p5l242t698r617b741],
10	side	JJ	O	side	amod	11	SENT_65	[p5l637t698r737b741],
11	effects	NNS	O	effect	prep_with	7	SENT_65	[p5l756t697r967b752],
12	.	.	O	.	_	0	SENT_65	[p5l756t697r967b752],
13	]	SYM	O	]	dep	3	SENT_65	[p5l756t697r967b752],

1	Am	VBP	O	be	dep	3	SENT_66	[p5l983t700r1071b741],
2	Coll	NNP	O	Coll	nn	3	SENT_66	[p5l1089t698r1185b741],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_66	[p5l1203t698r1385b741],
4	2009	CD	DATE	2009	num	3	SENT_66	[p5l1404t700r1877b748],
5	;	:	O	;	_	0	SENT_66	[p5l1404t700r1877b748],
6	54:1609	CD	NUMBER	54:1609	dep	3	SENT_66	[p5l1404t700r1877b748],
7	—	CD	NUMBER	—	num	8	SENT_66	[p5l1404t700r1877b748],
8	16	CD	NUMBER	16	dep	6	SENT_66	[p5l1404t700r1877b748],
9	.	.	O	.	_	0	SENT_66	[p5l1404t700r1877b748],

1	[	NN	O	[	_	0	SENT_67	[p5l7t764r72b818],
2	5	CD	NUMBER	5	num	1	SENT_67	[p5l7t764r72b818],
3	]	CD	NUMBER	]	num	5	SENT_67	[p5l7t764r72b818],
4	Golomb	NNP	ORGANIZATION	Golomb	nn	5	SENT_67	[p5l106t764r308b808],
5	BA	NN	ORGANIZATION	ba	dep	1	SENT_67	[p5l335t766r415b814],
6	,	,	O	,	_	0	SENT_67	[p5l335t766r415b814],
7	Evans	NNP	PERSON	Evans	nn	8	SENT_67	[p5l443t767r589b808],
8	MA	NNP	O	MA	appos	5	SENT_67	[p5l617t766r715b808],
9	.	.	O	.	_	0	SENT_67	[p5l617t766r715b808],

1	Statin	JJ	O	statin	_	0	SENT_68	[p5l743t765r891b808],
2	adverse	JJ	O	adverse	amod	3	SENT_68	[p5l917t764r1114b808],
3	effects	NNS	O	effect	dep	1	SENT_68	[p5l1142t764r1320b808],
4	.	.	O	.	_	0	SENT_68	[p5l1142t764r1320b808],

1	A	DT	O	a	det	2	SENT_69	[p5l1345t766r1384b807],
2	review	NN	O	review	_	0	SENT_69	[p5l1408t765r1584b808],
3	of	IN	O	of	_	0	SENT_69	[p5l1609t764r1662b808],
4	the	DT	O	the	det	5	SENT_69	[p5l1682t764r1763b808],
5	literature	NN	O	literature	prep_of	2	SENT_69	[p5l1791t764r2031b808],
6	and	CC	O	and	_	0	SENT_69	[p5l2058t764r2151b808],
7	evidence	NN	O	evidence	conj_and	5	SENT_69	[p5l106t829r334b873],
8	for	IN	O	for	_	0	SENT_69	[p5l353t829r425b873],
9	a	DT	O	a	det	11	SENT_69	[p5l442t842r468b873],
10	mitochondrial	JJ	O	mitochondrial	amod	11	SENT_69	[p5l486t829r852b873],
11	mechanisms	NNS	O	mechanism	prep_for	5	SENT_69	[p5l872t830r1207b873],
12	.	.	O	.	_	0	SENT_69	[p5l872t830r1207b873],

1	Am	VBP	O	be	dep	4	SENT_70	[p5l1224t831r1345b884],
2	]	CD	NUMBER	]	num	4	SENT_70	[p5l1224t831r1345b884],
3	Cardiovasc	JJ	O	cardiovasc	amod	4	SENT_70	[p5l1363t829r1641b873],
4	drugs	NNS	O	drug	_	0	SENT_70	[p5l1660t829r1802b884],
5	2008	CD	DATE	2008	dep	4	SENT_70	[p5l1821t832r2150b880],
6	;	:	O	;	_	0	SENT_70	[p5l1821t832r2150b880],
7	8:373	CD	NUMBER	8:373	num	8	SENT_70	[p5l1821t832r2150b880],
8	—	NN	O	—	dep	4	SENT_70	[p5l1821t832r2150b880],
9	418	CD	NUMBER	418	rcmod	8	SENT_70	[p5l105t899r213b941],
10	.	.	O	.	_	0	SENT_70	[p5l105t899r213b941],

1	[	NN	O	[	_	0	SENT_71	[p5l7t963r72b1018],
2	6	CD	NUMBER	6	num	1	SENT_71	[p5l7t963r72b1018],
3	]	CD	NUMBER	]	num	6	SENT_71	[p5l7t963r72b1018],
4	Knauer	NNP	PERSON	Knauer	nn	6	SENT_71	[p5l107t966r291b1007],
5	M	NN	O	m	nn	6	SENT_71	[p5l318t966r396b1018],
6	]	NN	O	]	dep	1	SENT_71	[p5l318t966r396b1018],
7	,	,	O	,	_	0	SENT_71	[p5l318t966r396b1018],
8	Urquhart	NNP	ORGANIZATION	Urquhart	nn	9	SENT_71	[p5l424t963r661b1018],
9	BL	NN	ORGANIZATION	bl	appos	6	SENT_71	[p5l687t966r758b1014],
10	,	,	O	,	_	0	SENT_71	[p5l687t966r758b1014],
11	Meyer	NNP	PERSON	Meyer	nn	12	SENT_71	[p5l787t966r951b1018],
12	Z	NNP	O	Z	appos	6	SENT_71	[p5l976t966r1017b1014],
13	,	,	O	,	_	0	SENT_71	[p5l976t966r1017b1014],
14	et	FW	O	et	nn	15	SENT_71	[p5l1046t970r1094b1007],
15	al.	FW	O	al.	appos	6	SENT_71	[p5l1121t963r1176b1007],
16	.	.	O	.	_	0	SENT_71	[p5l1121t963r1176b1007],

1	Human	JJ	O	human	amod	5	SENT_72	[p5l1204t966r1393b1007],
2	skeletal	JJ	O	skeletal	amod	5	SENT_72	[p5l1421t963r1616b1007],
3	muscle	NN	O	muscle	nn	5	SENT_72	[p5l1645t963r1826b1007],
4	drug	NN	O	drug	nn	5	SENT_72	[p5l1854t963r1973b1018],
5	transporters	NNS	O	transporter	nsubj	6	SENT_72	[p5l1999t970r2151b1007, p5l106t1035r290b1083],
6	determine	VBP	O	determine	_	0	SENT_72	[p5l305t1029r572b1072],
7	local	JJ	O	local	amod	8	SENT_72	[p5l587t1029r704b1072],
8	exposure	NN	O	exposure	dobj	6	SENT_72	[p5l719t1041r954b1083],
9	and	CC	O	and	_	0	SENT_72	[p5l969t1029r1062b1072],
10	toxicity	NN	O	toxicity	dobj	6	SENT_72	[p5l1076t1029r1272b1083],
11	of	IN	O	of	_	0	SENT_72	[p5l1285t1029r1339b1072],
12	statins	NNS	O	statin	prep_of	8	SENT_72	[p5l1347t1029r1528b1073],
13	.	.	O	.	_	0	SENT_72	[p5l1347t1029r1528b1073],

1	Circ	NNP	ORGANIZATION	Circ	nn	2	SENT_73	[p5l1544t1029r1641b1072],
2	Res	NNP	ORGANIZATION	Res	_	0	SENT_73	[p5l1656t1031r1741b1072],
3	2010	CD	DATE	2010	num	2	SENT_73	[p5l1756t1031r1929b1079],
4	;	:	O	;	_	0	SENT_73	[p5l1756t1031r1929b1079],
5	1	CD	NUMBER	1	number	6	SENT_73	[p5l1756t1031r1929b1079],
6	06:297306	CD	NUMBER	06:297306	dep	2	SENT_73	[p5l1939t1031r2150b1073, p5l105t1098r213b1140],
7	.	.	O	.	_	0	SENT_73	[p5l1939t1031r2150b1073, p5l105t1098r213b1140],

1	[	NN	O	[	_	0	SENT_74	[p5l8t1161r72b1216],
2	7	CD	NUMBER	7	num	3	SENT_74	[p5l8t1161r72b1216],
3	]	CD	NUMBER	]	dep	1	SENT_74	[p5l8t1161r72b1216],
4	Oh	UH	O	oh	dep	5	SENT_74	[p5l106t1161r220b1216],
5	]	CD	NUMBER	]	rcmod	3	SENT_74	[p5l106t1161r220b1216],
6	,	,	O	,	_	0	SENT_74	[p5l106t1161r220b1216],
7	Ban	NN	PERSON	ban	nn	8	SENT_74	[p5l238t1164r332b1205],
8	MR	NN	PERSON	mr	appos	3	SENT_74	[p5l348t1164r444b1212],
9	,	,	O	,	_	0	SENT_74	[p5l348t1164r444b1212],
10	Miskie	NNP	O	Miskie	nn	11	SENT_74	[p5l462t1161r630b1205],
11	BA	NN	O	ba	appos	8	SENT_74	[p5l648t1163r727b1212],
12	,	,	O	,	_	0	SENT_74	[p5l648t1163r727b1212],
13	et	FW	O	et	nn	14	SENT_74	[p5l745t1168r793b1205],
14	al.	FW	O	al.	appos	8	SENT_74	[p5l808t1161r863b1205],
15	.	.	O	.	_	0	SENT_74	[p5l808t1161r863b1205],

1	Genetic	JJ	O	genetic	amod	2	SENT_75	[p5l881t1162r1076b1205],
2	determinants	NNS	O	determinant	_	0	SENT_75	[p5l1092t1161r1438b1205],
3	of	IN	O	of	_	0	SENT_75	[p5l1456t1161r1509b1205],
4	statin	NN	O	statin	nn	5	SENT_75	[p5l1520t1162r1664b1205],
5	intolerance	NN	O	intolerance	prep_of	2	SENT_75	[p5l1680t1162r1983b1205],
6	.	.	O	.	_	0	SENT_75	[p5l1680t1162r1983b1205],

1	Lipids	NNS	O	lipid	_	0	SENT_76	[p5l2001t1161r2151b1216],

1	Health	NNP	O	Health	nn	2	SENT_77	[p5l107t1228r276b1271],
2	Dis	NNP	O	Dis	_	0	SENT_77	[p5l294t1229r372b1271],
3	2007	CD	DATE	2007	num	2	SENT_77	[p5l391t1230r635b1278],
4	;	:	O	;	_	0	SENT_77	[p5l391t1230r635b1278],
5	6:7	CD	NUMBER	6:7	dep	2	SENT_77	[p5l391t1230r635b1278],
6	.	.	O	.	_	0	SENT_77	[p5l391t1230r635b1278],

1	[	NN	O	[	nsubjpass	31	SENT_78	[p5l8t1294r72b1349],
2	8	CD	NUMBER	8	num	5	SENT_78	[p5l8t1294r72b1349],
3	]	NN	O	]	nn	5	SENT_78	[p5l8t1294r72b1349],
4	Puccetti	NN	PERSON	puccettus	nn	5	SENT_78	[p5l107t1295r311b1338],
5	L	NN	PERSON	l	dep	1	SENT_78	[p5l336t1297r372b1344],
6	,	,	O	,	_	0	SENT_78	[p5l336t1297r372b1344],
7	Pasqui	NNP	ORGANIZATION	Pasqui	nn	8	SENT_78	[p5l398t1295r564b1349],
8	AL	NNP	ORGANIZATION	AL	appos	5	SENT_78	[p5l586t1296r662b1344],
9	,	,	O	,	_	0	SENT_78	[p5l586t1296r662b1344],
10	Pastorelli	NNP	PERSON	Pastorelli	nn	11	SENT_78	[p5l688t1294r926b1338],
11	M	NNP	O	M	appos	5	SENT_78	[p5l952t1297r1013b1344],
12	,	,	O	,	_	0	SENT_78	[p5l952t1297r1013b1344],
13	et	FW	O	et	nn	14	SENT_78	[p5l1038t1301r1086b1338],
14	al.	FW	O	al.	appos	5	SENT_78	[p5l1109t1294r1164b1338],
15	3	CD	NUMBER	3	num	18	SENT_78	[p5l1188t1294r1393b1349],
16	’	NN	O	’	nn	18	SENT_78	[p5l1188t1294r1393b1349],
17	UTR/T	NN	O	utr/t	nn	18	SENT_78	[p5l1188t1294r1393b1349],
18	polymorphism	NN	O	polymorphism	dep	14	SENT_78	[p5l1415t1294r1796b1349],
19	of	IN	O	of	_	0	SENT_78	[p5l1820t1294r1873b1338],
20	lectin-like	JJ	O	lectin-like	prep_of	1	SENT_78	[p5l1891t1294r2151b1338],
21	oxidized	VBN	O	oxidize	partmod	20	SENT_78	[p5l106t1360r324b1403],
22	low-density	JJ	O	low-density	amod	25	SENT_78	[p5l351t1360r660b1414],
23	lipoprotein	NN	O	lipoprotein	nn	25	SENT_78	[p5l684t1360r971b1414],
24	receptor	NN	O	receptor	nn	25	SENT_78	[p5l996t1362r1261b1414],
25	—	NN	O	—	nsubj	29	SENT_78	[p5l996t1362r1261b1414],
26	1	CD	NUMBER	1	number	27	SENT_78	[p5l996t1362r1261b1414],
27	(	CD	NUMBER	(	num	29	SENT_78	[p5l1292t1360r1493b1414],
28	LOX-1	NN	O	lox-1	nn	29	SENT_78	[p5l1292t1360r1493b1414],
29	)	NN	O	)	xcomp	21	SENT_78	[p5l1292t1360r1493b1414],
30	is	VBZ	O	be	auxpass	31	SENT_78	[p5l1518t1361r1555b1403],
31	associated	VBN	O	associate	_	0	SENT_78	[p5l1581t1360r1847b1403],
32	with	IN	O	with	_	0	SENT_78	[p5l1870t1360r1989b1403],
33	modiﬁed	JJ	O	modiﬁed	amod	35	SENT_78	[p5l2015t1360r2151b1403, p5l107t1426r218b1470],
34	anti-platelet	JJ	O	anti-platelet	amod	35	SENT_78	[p5l251t1426r572b1481],
35	activity	NN	O	activity	prep_with	31	SENT_78	[p5l605t1427r796b1481],
36	of	IN	O	of	_	0	SENT_78	[p5l829t1426r882b1470],
37	atorvastatin	NN	O	atorvastatin	prep_of	35	SENT_78	[p5l909t1427r1220b1470],
38	in	IN	O	in	_	0	SENT_78	[p5l1253t1427r1300b1469],
39	hypercholesterolemic	JJ	O	hypercholesterolemic	amod	40	SENT_78	[p5l1334t1426r1897b1481],
40	subjects	NNS	O	subject	prep_in	31	SENT_78	[p5l1931t1426r2151b1481],
41	.	.	O	.	_	0	SENT_78	[p5l1931t1426r2151b1481],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_79	[p5l104t1492r501b1535],
2	2005	CD	DATE	2005	num	1	SENT_79	[p5l520t1494r961b1542],
3	;	:	O	;	_	0	SENT_79	[p5l520t1494r961b1542],
4	183:322	CD	NUMBER	183:322	number	5	SENT_79	[p5l520t1494r961b1542],
5	—	CD	NUMBER	—	dep	1	SENT_79	[p5l520t1494r961b1542],
6	8	CD	NUMBER	8	dep	5	SENT_79	[p5l520t1494r961b1542],
7	.	.	O	.	_	0	SENT_79	[p5l520t1494r961b1542],

1	[	NN	O	[	nn	4	SENT_80	[p5l7t1558r72b1612],
2	9	CD	NUMBER	9	num	4	SENT_80	[p5l7t1558r72b1612],
3	]	NN	O	]	nn	4	SENT_80	[p5l7t1558r72b1612],
4	Pasanen	NN	PERSON	pasanen	_	0	SENT_80	[p5l106t1561r317b1602],
5	MK	NN	O	mk	nn	17	SENT_80	[p5l335t1561r433b1608],
6	,	,	O	,	_	0	SENT_80	[p5l335t1561r433b1608],
7	Fredrikson	NN	PERSON	fredrikson	dep	17	SENT_80	[p5l452t1558r727b1602],
8	H	NN	PERSON	h	nn	17	SENT_80	[p5l745t1561r795b1608],
9	,	,	O	,	_	0	SENT_80	[p5l745t1561r795b1608],
10	Neuvonen	NN	PERSON	neuvonen	dep	17	SENT_80	[p5l815t1561r1078b1602],
11	P	NN	O	p	nn	17	SENT_80	[p5l1096t1561r1153b1612],
12	]	NN	O	]	nn	17	SENT_80	[p5l1096t1561r1153b1612],
13	,	,	O	,	_	0	SENT_80	[p5l1096t1561r1153b1612],
14	Niemi	NNP	PERSON	Niemi	dep	17	SENT_80	[p5l1173t1559r1326b1602],
15	M.	NNP	O	M.	nn	17	SENT_80	[p5l1345t1561r1406b1602],
16	Different	NNP	O	Different	nn	17	SENT_80	[p5l1425t1558r1656b1602],
17	effects	NNS	O	effect	dep	4	SENT_80	[p5l1673t1558r1839b1602],
18	of	IN	O	of	_	0	SENT_80	[p5l1858t1558r1911b1602],
19	SLCO1B1	NN	O	slco1b1	nn	20	SENT_80	[p5l1924t1560r2145b1602],
20	polymorphism	NN	O	polymorphism	prep_of	17	SENT_80	[p5l107t1623r487b1678],
21	on	IN	O	on	_	0	SENT_80	[p5l509t1636r572b1667],
22	the	DT	O	the	det	23	SENT_80	[p5l594t1624r675b1667],
23	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	20	SENT_80	[p5l698t1623r1157b1678],
24	of	IN	O	of	_	0	SENT_80	[p5l1181t1623r1234b1667],
25	atorvastatin	NN	O	atorvastatin	prep_of	23	SENT_80	[p5l1250t1624r1561b1667],
26	and	CC	O	and	_	0	SENT_80	[p5l1583t1623r1676b1667],
27	rosuvastatin	NN	O	rosuvastatin	prep_of	23	SENT_80	[p5l1699t1624r2030b1667],
28	.	.	O	.	_	0	SENT_80	[p5l1699t1624r2030b1667],

1	Clin	NNP	O	Clin	nn	3	SENT_81	[p5l2053t1623r2152b1667],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_81	[p5l107t1690r378b1733],
3	Ther	NNP	O	Ther	_	0	SENT_81	[p5l395t1690r514b1733],
4	2007	CD	DATE	2007	num	3	SENT_81	[p5l530t1692r655b1733],
5	;	:	O	;	_	0	SENT_81	[p5l664t1692r971b1740],
6	82:726	CD	NUMBER	82:726	number	7	SENT_81	[p5l664t1692r971b1740],
7	—	CD	NUMBER	—	dep	3	SENT_81	[p5l664t1692r971b1740],
8	33	CD	NUMBER	33	dep	7	SENT_81	[p5l664t1692r971b1740],
9	.	.	O	.	_	0	SENT_81	[p5l664t1692r971b1740],

1	Luca	NNP	PERSON	Luca	nn	4	SENT_82	[p5l1690t1859r1833b1910],
2	Puccetti	NNP	PERSON	Puccetti	nn	4	SENT_82	[p5l1856t1857r2111b1910],
3	*	NNP	O	*	nn	4	SENT_82	[p5l2125t1861r2146b1885],
4	Centre	NNP	O	Centre	_	0	SENT_82	[p5l1058t1947r1255b1999],
5	for	IN	O	for	_	0	SENT_82	[p5l1266t1944r1364b2013],
6	Atherosclerosis	NNP	ORGANIZATION	Atherosclerosis	nn	7	SENT_82	[p5l1375t1944r1842b1999],
7	Research	NNP	ORGANIZATION	Research	prep_for	4	SENT_82	[p5l1862t1944r2148b2007],
8	,	,	O	,	_	0	SENT_82	[p5l1862t1944r2148b2007],
9	University	NNP	ORGANIZATION	University	appos	7	SENT_82	[p5l1203t2034r1516b2102],
10	of	IN	ORGANIZATION	of	_	0	SENT_82	[p5l1537t2033r1604b2102],
11	Siena	NNP	ORGANIZATION	Siena	prep_of	9	SENT_82	[p5l1611t2034r1789b2097],
12	,	,	O	,	_	0	SENT_82	[p5l1611t2034r1789b2097],
13	Siena	NNP	LOCATION	Siena	nn	15	SENT_82	[p5l1812t2034r1990b2097],
14	,	,	O	,	_	0	SENT_82	[p5l1812t2034r1990b2097],
15	Italy	NNP	LOCATION	Italy	dep	4	SENT_82	[p5l2013t2033r2152b2102],

1	Federica	NNP	PERSON	Federica	nn	4	SENT_83	[p5l1701t2168r1970b2222],
2	Ciani	NNP	PERSON	Ciani	nn	4	SENT_83	[p5l1992t2169r2150b2222],
3	Neurometabolic	NNP	O	Neurometabolic	nn	4	SENT_83	[p5l705t2256r1200b2311],
4	Unit	NNP	O	Unit	_	0	SENT_83	[p5l1222t2257r1362b2320],
5	,	,	O	,	_	0	SENT_83	[p5l1222t2257r1362b2320],
6	Meyer	NNP	ORGANIZATION	Meyer	nn	8	SENT_83	[p5l1385t2260r1583b2325],
7	Children	NNP	ORGANIZATION	Children	nn	8	SENT_83	[p5l1602t2256r1858b2311],
8	Hospital	NNP	ORGANIZATION	Hospital	appos	4	SENT_83	[p5l1879t2256r2148b2325],
9	,	,	O	,	_	0	SENT_83	[p5l1879t2256r2148b2325],
10	Florence	NNP	LOCATION	Florence	appos	4	SENT_83	[p5l1720t2346r1990b2409],
11	,	,	O	,	_	0	SENT_83	[p5l1720t2346r1990b2409],
12	Italy	NNP	LOCATION	Italy	appos	4	SENT_83	[p5l2014t2345r2152b2414],

1	Alberto	NNP	PERSON	Alberto	nn	3	SENT_84	[p5l1691t2481r1930b2535],
2	Auteri	NNP	PERSON	Auteri	nn	3	SENT_84	[p5l1950t2481r2150b2535],
3	Centre	NNP	ORGANIZATION	Centre	_	0	SENT_84	[p5l1058t2572r1255b2624],
4	for	IN	ORGANIZATION	for	_	0	SENT_84	[p5l1266t2569r1364b2637],
5	Atherosclerosis	NNP	ORGANIZATION	Atherosclerosis	nn	6	SENT_84	[p5l1375t2569r1842b2624],
6	Research	NNP	ORGANIZATION	Research	prep_for	3	SENT_84	[p5l1862t2569r2148b2632],
7	,	,	O	,	_	0	SENT_84	[p5l1862t2569r2148b2632],
8	University	NNP	ORGANIZATION	University	appos	6	SENT_84	[p5l1203t2659r1516b2727],
9	of	IN	ORGANIZATION	of	_	0	SENT_84	[p5l1537t2658r1604b2727],
10	Siena	NNP	ORGANIZATION	Siena	prep_of	8	SENT_84	[p5l1611t2659r1789b2721],
11	,	,	O	,	_	0	SENT_84	[p5l1611t2659r1789b2721],
12	Siena	NNP	LOCATION	Siena	nn	14	SENT_84	[p5l1812t2659r1990b2721],
13	,	,	O	,	_	0	SENT_84	[p5l1812t2659r1990b2721],
14	Italy	NNP	LOCATION	Italy	dep	3	SENT_84	[p5l2014t2658r2152b2727],

1	*	NN	O	*	_	0	SENT_85	[p5l546t2840r567b2865],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_85	[p5l585t2835r1061b2904],
3	author	NN	O	author	dobj	2	SENT_85	[p5l1082t2835r1297b2890],
4	at	IN	O	at	prep	2	SENT_85	[p5l1317t2843r1395b2891],
5	:	:	O	:	_	0	SENT_85	[p5l1317t2843r1395b2891],
6	Department	NNP	O	Department	dep	1	SENT_85	[p5l1423t2839r1813b2904],
7	of	IN	O	of	_	0	SENT_85	[p5l1834t2835r1901b2890],
8	Clinical	JJ	O	clinical	amod	11	SENT_85	[p5l1915t2835r2150b2890],
9	and	CC	O	and	_	0	SENT_85	[p5l649t2925r765b2980],
10	Emergency	NN	ORGANIZATION	emergency	amod	11	SENT_85	[p5l789t2928r1147b2993],
11	Medicine	NN	ORGANIZATION	medicine	prep_of	6	SENT_85	[p5l1169t2925r1480b2988],
12	,	,	O	,	_	0	SENT_85	[p5l1169t2925r1480b2988],
13	Internal	JJ	ORGANIZATION	internal	amod	14	SENT_85	[p5l1504t2925r1756b2980],
14	Medicine	NN	ORGANIZATION	medicine	appos	11	SENT_85	[p5l1780t2925r2075b2980],
15	3	CD	NUMBER	3	num	14	SENT_85	[p5l2097t2927r2150b2988],
16	,	,	O	,	_	0	SENT_85	[p5l2097t2927r2150b2988],
17	Santa	NNP	ORGANIZATION	Santa	nn	22	SENT_85	[p5l508t3017r683b3069],
18	Maria	NNP	ORGANIZATION	Maria	nn	22	SENT_85	[p5l705t3015r889b3069],
19	Alle	NNP	ORGANIZATION	Alle	nn	22	SENT_85	[p5l909t3014r1033b3069],
20	Scotte	NNP	ORGANIZATION	Scotte	nn	22	SENT_85	[p5l1056t3017r1251b3069],
21	University	NNP	ORGANIZATION	University	nn	22	SENT_85	[p5l1274t3015r1608b3082],
22	Hospital	NNP	ORGANIZATION	Hospital	appos	11	SENT_85	[p5l1629t3014r1912b3082],
23	,	,	O	,	_	0	SENT_85	[p5l1629t3014r1912b3082],
24	53100	CD	NUMBER	53100	appos	11	SENT_85	[p5l1936t3017r2150b3077],
25	,	,	O	,	_	0	SENT_85	[p5l1936t3017r2150b3077],
26	Siena	NNP	LOCATION	Siena	appos	11	SENT_85	[p5l1021t3103r1207b3165],
27	,	,	O	,	_	0	SENT_85	[p5l1021t3103r1207b3165],
28	Italy	NNP	LOCATION	Italy	appos	11	SENT_85	[p5l1231t3102r1386b3171],
29	.	.	O	.	_	0	SENT_85	[p5l1231t3102r1386b3171],

1	Tel.	NNP	O	Tel.	_	0	SENT_86	[p5l1407t3102r1538b3158],
2	:	:	O	:	_	0	SENT_86	[p5l1407t3102r1538b3158],
3	+39 0577 585741	CD	NUMBER	+39 0577 585741	dep	1	SENT_86	[p5l1887t3105r2146b3165],[p5l1566t3105r1681b3157],
4	;	:	O	;	_	0	SENT_86	[p5l1887t3105r2146b3165],
5	fax	NN	O	fax	dep	3	SENT_86	[p5l1474t3191r1587b3246],
6	:	:	O	:	_	0	SENT_86	[p5l1474t3191r1587b3246],
7	+39 0577 441	CD	NUMBER	+39 0577 441	number	8	SENT_86	[p5l1933t3194r2045b3245],[p5l1615t3194r1730b3245],
8	14	CD	NUMBER	14	dep	5	SENT_86	[p5l2061t3194r2150b3246],
9	.	.	O	.	_	0	SENT_86	[p5l2061t3194r2150b3246],

1	E	NN	O	e	nn	4	SENT_87	[p5l1112t3279r1317b3334],
2	—	CD	NUMBER	—	num	4	SENT_87	[p5l1112t3279r1317b3334],
3	mail	NN	O	mail	nn	4	SENT_87	[p5l1112t3279r1317b3334],
4	address	NN	O	address	_	0	SENT_87	[p5l1337t3279r1589b3335],
5	:	:	O	:	_	0	SENT_87	[p5l1337t3279r1589b3335],
6	puccetti@unisi.it	NN	O	puccetti@unisi.it	dep	4	SENT_87	[p5l1614t3280r2153b3348],
7	(	CD	NUMBER	(	num	10	SENT_87	[p5l1756t3369r1828b3437],
8	L.	NNP	PERSON	L.	nn	10	SENT_87	[p5l1756t3369r1828b3437],
9	Puccetti	NNP	PERSON	Puccetti	nn	10	SENT_87	[p5l1853t3369r2150b3437],
10	)	NN	O	)	dep	6	SENT_87	[p5l1853t3369r2150b3437],
11	.	.	O	.	_	0	SENT_87	[p5l1853t3369r2150b3437],

1	22	CD	DATE	22	num	2	SENT_88	[p5l1544t3548r1619b3599],
2	December	NNP	DATE	December	_	0	SENT_88	[p5l1644t3545r1972b3599],
3	2009	CD	DATE	2009	num	2	SENT_88	[p5l1992t3548r2150b3599],
4	Available	JJ	O	available	dep	2	SENT_88	[p5l1042t3633r1340b3688],
5	online	NN	O	online	prep	4	SENT_88	[p5l1363t3633r1563b3688],
6	25	CD	DATE	25	dep	5	SENT_88	[p5l1586t3636r1660b3688],
7	February	NNP	DATE	February	tmod	4	SENT_88	[p5l1685t3633r1972b3702],
8	2010	CD	DATE	2010	num	7	SENT_88	[p5l1992t3636r2151b3688],

